ReactomeID,filename
Neuronal System,R-HSA-112316
SALM protein interactions at the synapses,R-HSA-8849932
Potassium Channels,R-HSA-1296071
Voltage gated Potassium channels,R-HSA-1296072
Tandem pore domain potassium channels,R-HSA-1296346
TWIK-releated acid-sensitive K+ channel (TASK),R-HSA-1299316
TWIK-related alkaline pH activated K+ channel (TALK),R-HSA-1299361
TWIK-related spinal cord K+ channel (TRESK),R-HSA-1299344
TWIK related potassium channel (TREK),R-HSA-1299503
Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK),R-HSA-1299308
Tandem pore domain halothane-inhibited K+ channel (THIK),R-HSA-1299287
HCN channels,R-HSA-1296061
Inwardly rectifying K+ channels,R-HSA-1296065
Classical Kir channels,R-HSA-1296053
Potassium transport channels,R-HSA-1296067
G protein gated Potassium channels,R-HSA-1296059
Activation of G protein gated Potassium channels,R-HSA-1296041
ATP sensitive Potassium channels,R-HSA-1296025
Ca2+ activated K+ channels,R-HSA-1296052
Transmission across Chemical Synapses,R-HSA-112315
Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels,R-HSA-112308
Neurotransmitter Clearance In The Synaptic Cleft,R-HSA-112311
Serotonin clearance from the synaptic cleft,R-HSA-380615
Metabolism of serotonin,R-HSA-380612
Dopamine clearance from the synaptic cleft,R-HSA-379401
Enzymatic degradation of dopamine by COMT,R-HSA-379397
Enzymatic degradation of Dopamine by monoamine oxidase,R-HSA-379398
Neurotransmitter uptake and Metabolism In Glial Cells,R-HSA-112313
Astrocytic Glutamate-Glutamine Uptake And Metabolism,R-HSA-210455
Neurotransmitter Release Cycle,R-HSA-112310
Norepinephrine Neurotransmitter Release Cycle,R-HSA-181430
Acetylcholine Neurotransmitter Release Cycle,R-HSA-264642
Serotonin Neurotransmitter Release Cycle,R-HSA-181429
Dopamine Neurotransmitter Release Cycle,R-HSA-212676
"GABA synthesis, release, reuptake and degradation",R-HSA-888590
Reuptake of GABA,R-HSA-888593
Degradation of GABA,R-HSA-916853
GABA synthesis,R-HSA-888568
Glutamate Neurotransmitter Release Cycle,R-HSA-210500
Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell,R-HSA-112314
Activation of Kainate Receptors upon glutamate binding,R-HSA-451326
Ionotropic activity of Kainate Receptors,R-HSA-451306
Activation of Ca-permeable Kainate Receptor,R-HSA-451308
Activation of Na-permeable Kainate Receptors,R-HSA-451307
Presynaptic function of Kainate receptors,R-HSA-500657
Acetylcholine Binding And Downstream Events,R-HSA-181431
Activation of Nicotinic Acetylcholine Receptors,R-HSA-629602
Postsynaptic nicotinic acetylcholine receptors,R-HSA-622327
Highly sodium permeable acetylcholine nicotinic receptors,R-HSA-629587
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors,R-HSA-629594
Presynaptic nicotinic acetylcholine receptors,R-HSA-622323
Highly calcium permeable nicotinic acetylcholine receptors,R-HSA-629597
Highly sodium permeable acetylcholine nicotinic receptors,R-HSA-629587
Activation of NMDA receptor upon glutamate binding and postsynaptic events,R-HSA-442755
"Unblocking of NMDA receptor, glutamate binding and activation",R-HSA-438066
Post NMDA receptor activation events,R-HSA-438064
CREB phosphorylation through the activation of CaMKII,R-HSA-442729
CREB phosphorylation through the activation of CaMKK,R-HSA-442717
Activation of CaMK IV,R-HSA-442745
CREB phosphorylation through the activation of Adenylate Cyclase,R-HSA-442720
CREB phosphorylation through the activation of Ras,R-HSA-442742
Ras activation uopn Ca2+ infux through NMDA receptor,R-HSA-442982
RSK activation,R-HSA-444257
"Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity",R-HSA-399721
Trafficking of AMPA receptors,R-HSA-399719
Trafficking of GluR2-containing AMPA receptors,R-HSA-416993
Activation of AMPA receptors,R-HSA-399710
GABA receptor activation,R-HSA-977443
GABA A receptor activation,R-HSA-977441
GABA A (rho) receptor activation,R-HSA-977442
GABA B receptor activation,R-HSA-977444
Activation of GABAB receptors,R-HSA-991365
Inhibition of adenylate cyclase pathway,R-HSA-997269
Adenylate cyclase inhibitory pathway,R-HSA-170670
Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,R-HSA-997272
Protein-protein interactions at synapses,R-HSA-6794362
Interactions of neurexins and neuroligins at synapses,R-HSA-6794361
Transmission across Electrical Synapses,R-HSA-112307
Electric Transmission Across Gap Junctions,R-HSA-112303
Metabolism,R-HSA-1430728
Pyrophosphate hydrolysis,R-HSA-71737
Mitochondrial iron-sulfur cluster biogenesis,R-HSA-1362409
Electron transport from NADPH to Ferredoxin,R-HSA-2395516
Metabolism of porphyrins,R-HSA-189445
Heme degradation,R-HSA-189483
Heme biosynthesis,R-HSA-189451
Cytosolic iron-sulfur cluster assembly,R-HSA-2564830
Reversible hydration of carbon dioxide,R-HSA-1475029
The citric acid (TCA) cycle and respiratory electron transport,R-HSA-1428517
"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",R-HSA-163200
Formation of ATP by chemiosmotic coupling,R-HSA-163210
Respiratory electron transport,R-HSA-611105
Complex I biogenesis,R-HSA-6799198
Mitochondrial Uncoupling Proteins,R-HSA-166187
The fatty acid cycling model,R-HSA-167826
The proton buffering model,R-HSA-167827
Pyruvate metabolism and Citric Acid (TCA) cycle,R-HSA-71406
Citric acid cycle (TCA cycle),R-HSA-71403
Pyruvate metabolism,R-HSA-70268
Regulation of pyruvate dehydrogenase (PDH) complex,R-HSA-204174
Interconversion of 2-oxoglutarate and 2-hydroxyglutarate,R-HSA-880009
Metabolism of amino acids and derivatives,R-HSA-71291
Sulfur amino acid metabolism,R-HSA-1614635
Degradation of cysteine and homocysteine,R-HSA-1614558
Sulfide oxidation to sulfate,R-HSA-1614517
Methionine salvage pathway,R-HSA-1237112
Cysteine formation from homocysteine,R-HSA-1614603
Melanin biosynthesis,R-HSA-5662702
Amino acid synthesis and interconversion (transamination),R-HSA-70614
Serine biosynthesis,R-HSA-977347
Glyoxylate metabolism and glycine degradation,R-HSA-389661
Glycine degradation,R-HSA-6783984
Selenoamino acid metabolism,R-HSA-2408522
"Metabolism of ingested SeMet, Sec, MeSec into H2Se",R-HSA-2408508
Selenocysteine synthesis,R-HSA-2408557
Methylation of MeSeH for excretion,R-HSA-2408552
Formation of selenosugars for excretion,R-HSA-2408499
Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,R-HSA-2408550
Metabolism of ingested MeSeO2H into MeSeH,R-HSA-5263617
SeMet incorporation into proteins,R-HSA-2408517
Branched-chain amino acid catabolism,R-HSA-70895
Carnitine synthesis,R-HSA-71262
Metabolism of polyamines,R-HSA-351202
Regulation of ornithine decarboxylase (ODC),R-HSA-350562
Interconversion of polyamines,R-HSA-351200
Creatine metabolism,R-HSA-71288
Methionine salvage pathway,R-HSA-1237112
Urea cycle,R-HSA-70635
Agmatine biosynthesis,R-HSA-351143
Amine-derived hormones,R-HSA-209776
Serotonin and melatonin biosynthesis,R-HSA-209931
Thyroxine biosynthesis,R-HSA-209968
Regulation of thyroid hormone activity,R-HSA-350864
Catecholamine biosynthesis,R-HSA-209905
Threonine catabolism,R-HSA-8849175
"Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism",R-HSA-6788656
Lysine catabolism,R-HSA-71064
Histidine catabolism,R-HSA-70921
Proline catabolism,R-HSA-70688
Phenylalanine and tyrosine catabolism,R-HSA-71182
Tryptophan catabolism,R-HSA-71240
Metabolism of lipids and lipoproteins,R-HSA-556833
Arachidonic acid metabolism,R-HSA-2142753
Synthesis of Prostaglandins (PG) and Thromboxanes (TX),R-HSA-2162123
Synthesis of 5-eicosatetraenoic acids,R-HSA-2142688
Synthesis of 15-eicosatetraenoic acid derivatives,R-HSA-2142770
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),R-HSA-2142670
Synthesis of Lipoxins (LX),R-HSA-2142700
Synthesis of Leukotrienes (LT) and Eoxins (EX),R-HSA-2142691
Synthesis of 12-eicosatetraenoic acid derivatives,R-HSA-2142712
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),R-HSA-2142816
Synthesis of Hepoxilins (HX) and Trioxilins (TrX),R-HSA-2142696
Regulation of cholesterol biosynthesis by SREBP (SREBF),R-HSA-1655829
Activation of gene expression by SREBF (SREBP),R-HSA-2426168
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,R-HSA-2046104
Linoleic acid (LA) metabolism,R-HSA-2046105
alpha-linolenic acid (ALA) metabolism,R-HSA-2046106
"Lipid digestion, mobilization, and transport",R-HSA-73923
Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis,R-HSA-163560
Trafficking of dietary sterols,R-HSA-265473
Digestion of dietary lipid,R-HSA-192456
Lipoprotein metabolism,R-HSA-174824
VLDL interactions,R-HSA-8855121
Reelin signalling pathway,R-HSA-8866376
VLDLR internalisation and degradation,R-HSA-8866427
VLDL biosynthesis,R-HSA-8866423
Chylomicron-mediated lipid transport,R-HSA-174800
HDL-mediated lipid transport,R-HSA-194223
LDL-mediated lipid transport,R-HSA-171052
Wax biosynthesis,R-HSA-8848584
Phospholipid metabolism,R-HSA-1483257
Glycerophospholipid biosynthesis,R-HSA-1483206
Synthesis of CL,R-HSA-1483076
Acyl chain remodelling of PC,R-HSA-1482788
Synthesis of PE,R-HSA-1483213
Acyl chain remodelling of PS,R-HSA-1482801
Choline catabolism,R-HSA-6798163
Hydrolysis of LPE,R-HSA-1483152
Acyl chain remodelling of PE,R-HSA-1482839
Synthesis of PS,R-HSA-1483101
Synthesis of PA,R-HSA-1483166
Hydrolysis of LPC,R-HSA-1483115
Acyl chain remodeling of DAG and TAG,R-HSA-1482883
Acyl chain remodelling of PG,R-HSA-1482925
Synthesis of BMP,R-HSA-1483171
Synthesis of PG,R-HSA-1483148
Synthesis of PI,R-HSA-1483226
Acyl chain remodelling of PI,R-HSA-1482922
Synthesis of PC,R-HSA-1483191
PI and PC transport between ER and Golgi membranes,R-HSA-1483196
Acyl chain remodeling of CL,R-HSA-1482798
PI Metabolism,R-HSA-1483255
PIPs transport between late endosome and Golgi membranes,R-HSA-1660508
Synthesis of PIPs at the plasma membrane,R-HSA-1660499
Glycerophospholipid catabolism,R-HSA-6814848
PIPs transport between plasma and early endosome membranes,R-HSA-1660524
PIPs transport between early and late endosome membranes,R-HSA-1660502
Synthesis of PIPs at the Golgi membrane,R-HSA-1660514
PIPs transport between early endosome and Golgi membranes,R-HSA-1660537
PI and PC transport between ER and Golgi membranes,R-HSA-1483196
Synthesis of PIPs at the early endosome membrane,R-HSA-1660516
Synthesis of PIPs at the ER membrane,R-HSA-1483248
Synthesis of PIPs at the late endosome membrane,R-HSA-1660517
PIPs transport between Golgi and plasma membranes,R-HSA-1660510
Bile acid and bile salt metabolism,R-HSA-194068
Recycling of bile acids and salts,R-HSA-159418
Synthesis of bile acids and bile salts,R-HSA-192105
Synthesis of bile acids and bile salts via 24-hydroxycholesterol,R-HSA-193775
Synthesis of bile acids and bile salts via 27-hydroxycholesterol,R-HSA-193807
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,R-HSA-193368
Metabolism of steroid hormones,R-HSA-196071
Mineralocorticoid biosynthesis,R-HSA-193993
Glucocorticoid biosynthesis,R-HSA-194002
Estrogen biosynthesis,R-HSA-193144
Androgen biosynthesis,R-HSA-193048
Pregnenolone biosynthesis,R-HSA-196108
Cholesterol biosynthesis,R-HSA-191273
Cholesterol biosynthesis via desmosterol,R-HSA-6807047
Cholesterol biosynthesis via lathosterol,R-HSA-6807062
Ubiquinol biosynthesis,R-HSA-2142789
Sphingolipid metabolism,R-HSA-428157
Sphingolipid de novo biosynthesis,R-HSA-1660661
Glycosphingolipid metabolism,R-HSA-1660662
"Fatty acid, triacylglycerol, and ketone body metabolism",R-HSA-535734
Ketone body metabolism,R-HSA-74182
Synthesis of Ketone Bodies,R-HSA-77111
Utilization of Ketone Bodies,R-HSA-77108
Import of palmitoyl-CoA into the mitochondrial matrix,R-HSA-200425
Triglyceride Biosynthesis,R-HSA-75109
Fatty Acyl-CoA Biosynthesis,R-HSA-75105
Synthesis of very long-chain fatty acyl-CoAs,R-HSA-75876
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha),R-HSA-400206
PPARA activates gene expression,R-HSA-1989781
Mitochondrial Fatty Acid Beta-Oxidation,R-HSA-77289
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids,R-HSA-77288
Propionyl-CoA catabolism,R-HSA-71032
mitochondrial fatty acid beta-oxidation of saturated fatty acids,R-HSA-77286
Beta oxidation of hexanoyl-CoA to butanoyl-CoA,R-HSA-77350
Beta oxidation of myristoyl-CoA to lauroyl-CoA,R-HSA-77285
Beta oxidation of butanoyl-CoA to acetyl-CoA,R-HSA-77352
Beta oxidation of palmitoyl-CoA to myristoyl-CoA,R-HSA-77305
Beta oxidation of octanoyl-CoA to hexanoyl-CoA,R-HSA-77348
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA,R-HSA-77346
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA,R-HSA-77310
Peroxisomal lipid metabolism,R-HSA-390918
Plasmalogen biosynthesis,R-HSA-75896
Alpha-oxidation of phytanate,R-HSA-389599
Beta-oxidation of very long chain fatty acids,R-HSA-390247
Beta-oxidation of pristanoyl-CoA,R-HSA-389887
NADPH regeneration,R-HSA-389542
Inositol phosphate metabolism,R-HSA-1483249
IPs transport between ER lumen and cytosol,R-HSA-1855215
IP3 and IP4 transport between cytosol and nucleus,R-HSA-1855196
Synthesis of pyrophosphates in the cytosol,R-HSA-1855167
Synthesis of IPs in the ER lumen,R-HSA-1855231
IPs transport between cytosol and ER lumen,R-HSA-1855184
Synthesis of IP3 and IP4 in the cytosol,R-HSA-1855204
IP6 and IP7 transport between cytosol and nucleus,R-HSA-1855229
IPs transport between nucleus and cytosol,R-HSA-1855170
Synthesis of IPs in the nucleus,R-HSA-1855191
IPs transport between nucleus and ER lumen,R-HSA-1855192
"Synthesis of IP2, IP, and Ins in the cytosol",R-HSA-1855183
IPs transport between ER lumen and nucleus,R-HSA-1855156
Biological oxidations,R-HSA-211859
Aflatoxin activation and detoxification,R-HSA-5423646
Phase 1 - Functionalization of compounds,R-HSA-211945
Amine Oxidase reactions,R-HSA-140179
PAOs oxidise polyamines to amines,R-HSA-141334
Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB,R-HSA-141333
Cytochrome P450 - arranged by substrate type,R-HSA-211897
Xenobiotics,R-HSA-211981
Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2,R-HSA-211957
CYP2E1 reactions,R-HSA-211999
Eicosanoids,R-HSA-211979
Fatty acids,R-HSA-211935
Miscellaneous substrates,R-HSA-211958
Endogenous sterols,R-HSA-211976
Sterols are 12-hydroxylated by CYP8B1,R-HSA-211994
Vitamins,R-HSA-211916
COX reactions,R-HSA-140180
Ethanol oxidation,R-HSA-71384
FMO oxidises nucleophiles,R-HSA-217271
Phase II conjugation,R-HSA-156580
Amino Acid conjugation,R-HSA-156587
Conjugation of carboxylic acids,R-HSA-159424
Conjugation of benzoate with glycine,R-HSA-177135
Conjugation of phenylacetate with glutamine,R-HSA-177162
Conjugation of salicylate with glycine,R-HSA-177128
Glutathione conjugation,R-HSA-156590
Glutathione synthesis and recycling,R-HSA-174403
Glucuronidation,R-HSA-156588
"Formation of the active cofactor, UDP-glucuronate",R-HSA-173599
Cytosolic sulfonation of small molecules,R-HSA-156584
Transport and synthesis of PAPS,R-HSA-174362
Methylation,R-HSA-156581
Acetylation,R-HSA-156582
Metabolism of nucleotides,R-HSA-15869
Phosphate bond hydrolysis by NTPDase proteins,R-HSA-8850843
Purine metabolism,R-HSA-73847
Purine ribonucleoside monophosphate biosynthesis,R-HSA-73817
Purine salvage,R-HSA-74217
Purine catabolism,R-HSA-74259
Synthesis and interconversion of nucleotide di- and triphosphates,R-HSA-499943
Pyrimidine metabolism,R-HSA-73848
Pyrimidine catabolism,R-HSA-73621
Pyrimidine salvage reactions,R-HSA-73614
Pyrimidine biosynthesis,R-HSA-500753
Phosphate bond hydrolysis by NUDT proteins,R-HSA-2393930
Integration of energy metabolism,R-HSA-163685
PP2A-mediated dephosphorylation of key metabolic factors,R-HSA-163767
ChREBP activates metabolic gene expression,R-HSA-163765
AMPK inhibits chREBP transcriptional activation activity,R-HSA-163680
Insulin effects increased synthesis of Xylulose-5-Phosphate,R-HSA-163754
Regulation of insulin secretion,R-HSA-422356
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,R-HSA-381676
Acetylcholine regulates insulin secretion,R-HSA-399997
"Adrenaline,noradrenaline inhibits insulin secretion",R-HSA-400042
Free fatty acids regulate insulin secretion,R-HSA-400451
Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion,R-HSA-434316
Glucagon signaling in metabolic regulation,R-HSA-163359
PKA activation in glucagon signalling,R-HSA-164378
PKA-mediated phosphorylation of key metabolic factors,R-HSA-163358
Response to metal ions,R-HSA-5660526
Metallothioneins bind metals,R-HSA-5661231
Metabolism of vitamins and cofactors,R-HSA-196854
Metabolism of fat-soluble vitamins,R-HSA-6806667
Metabolism of vitamin K,R-HSA-6806664
Vitamin D (calciferol) metabolism,R-HSA-196791
Retinoid metabolism and transport,R-HSA-975634
Metabolism of water-soluble vitamins and cofactors,R-HSA-196849
Nicotinate metabolism,R-HSA-196807
Nicotinamide salvaging,R-HSA-197264
Vitamin B2 (riboflavin) metabolism,R-HSA-196843
Vitamin C (ascorbate) metabolism,R-HSA-196836
Vitamins B6 activation to pyridoxal phosphate,R-HSA-964975
Vitamin B5 (pantothenate) metabolism,R-HSA-199220
Coenzyme A biosynthesis,R-HSA-196783
Biotin transport and metabolism,R-HSA-196780
Vitamin B1 (thiamin) metabolism,R-HSA-196819
Metabolism of folate and pterines,R-HSA-196757
Molybdenum cofactor biosynthesis,R-HSA-947581
"Cobalamin (Cbl, vitamin B12) transport and metabolism",R-HSA-196741
Metabolism of nitric oxide,R-HSA-202131
eNOS activation and regulation,R-HSA-203765
NOSTRIN mediated eNOS trafficking,R-HSA-203641
NOSIP mediated eNOS trafficking,R-HSA-203754
eNOS activation,R-HSA-203615
"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",R-HSA-1474151
O2/CO2 exchange in erythrocytes,R-HSA-1480926
Erythrocytes take up oxygen and release carbon dioxide,R-HSA-1247673
Erythrocytes take up carbon dioxide and release oxygen,R-HSA-1237044
Metabolism of carbohydrates,R-HSA-71387
Hexose transport,R-HSA-189200
Glucose transport,R-HSA-70153
Regulation of Glucokinase by Glucokinase Regulatory Protein,R-HSA-170822
Galactose catabolism,R-HSA-70370
Digestion of dietary carbohydrate,R-HSA-189085
Glycosaminoglycan metabolism,R-HSA-1630316
Transport and synthesis of PAPS,R-HSA-174362
Hyaluronan metabolism,R-HSA-2142845
Hyaluronan uptake and degradation,R-HSA-2160916
Hyaluronan biosynthesis and export,R-HSA-2142850
Heparan sulfate/heparin (HS-GAG) metabolism,R-HSA-1638091
HS-GAG biosynthesis,R-HSA-2022928
A tetrasaccharide linker sequence is required for GAG synthesis,R-HSA-1971475
HS-GAG degradation,R-HSA-2024096
Keratan sulfate/keratin metabolism,R-HSA-1638074
Keratan sulfate biosynthesis,R-HSA-2022854
Keratan sulfate degradation,R-HSA-2022857
Chondroitin sulfate/dermatan sulfate metabolism,R-HSA-1793185
CS/DS degradation,R-HSA-2024101
Dermatan sulfate biosynthesis,R-HSA-2022923
Chondroitin sulfate biosynthesis,R-HSA-2022870
A tetrasaccharide linker sequence is required for GAG synthesis,R-HSA-1971475
Glucose metabolism,R-HSA-70326
Glycolysis,R-HSA-70171
Glycogen breakdown (glycogenolysis),R-HSA-70221
Lysosomal glycogen catabolism,R-HSA-5357572
Glycogen synthesis,R-HSA-3322077
Gluconeogenesis,R-HSA-70263
Lysosomal oligosaccharide catabolism,R-HSA-8853383
Lactose synthesis,R-HSA-5653890
Catabolism of glucuronate to xylulose-5-phosphate,R-HSA-5661270
5-Phosphoribose 1-diphosphate biosynthesis,R-HSA-73843
Pentose phosphate pathway (hexose monophosphate shunt),R-HSA-71336
Fructose metabolism,R-HSA-5652084
Fructose biosynthesis,R-HSA-5652227
Fructose catabolism,R-HSA-70350
Abacavir transport and metabolism,R-HSA-2161522
Abacavir metabolism,R-HSA-2161541
Abacavir transmembrane transport,R-HSA-2161517
Developmental Biology,R-HSA-1266738
Transcriptional regulation of white adipocyte differentiation,R-HSA-381340
Regulation of beta-cell development,R-HSA-186712
Regulation of gene expression in early pancreatic precursor cells,R-HSA-210747
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,R-HSA-210744
Regulation of gene expression in beta cells,R-HSA-210745
AKT-mediated inactivation of FOXO1A,R-HSA-211163
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells,R-HSA-210746
Myogenesis,R-HSA-525793
CDO in myogenesis,R-HSA-375170
Axon guidance,R-HSA-422475
NCAM signaling for neurite out-growth,R-HSA-375165
NCAM1 interactions,R-HSA-419037
RAF/MAP kinase cascade,R-HSA-5673001
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
Regulation of RAS by GAPs,R-HSA-5658442
MAP2K and MAPK activation,R-HSA-5674135
RAF activation,R-HSA-5673000
Netrin-1 signaling,R-HSA-373752
Netrin mediated repulsion signals,R-HSA-418886
Role of second messengers in netrin-1 signaling,R-HSA-418890
DCC mediated attractive signaling,R-HSA-418885
Signaling by Robo receptor,R-HSA-376176
Role of Abl in Robo-Slit signaling,R-HSA-428890
Activation of Rac,R-HSA-428540
Inactivation of Cdc42 and Rac,R-HSA-428543
Regulation of Commissural axon pathfinding by Slit and Robo,R-HSA-428542
L1CAM interactions,R-HSA-373760
CHL1 interactions,R-HSA-447041
NrCAM interactions,R-HSA-447038
Neurofascin interactions,R-HSA-447043
Interaction between L1 and Ankyrins,R-HSA-445095
Recycling pathway of L1,R-HSA-437239
Signal transduction by L1,R-HSA-445144
EPH-Ephrin signaling,R-HSA-2682334
EPHB-mediated forward signaling,R-HSA-3928662
EPH-ephrin mediated repulsion of cells,R-HSA-3928665
EPHA-mediated growth cone collapse,R-HSA-3928663
Ephrin signaling,R-HSA-3928664
RET signaling,R-HSA-8853659
RAF/MAP kinase cascade,R-HSA-5673001
MAP2K and MAPK activation,R-HSA-5674135
Regulation of RAS by GAPs,R-HSA-5658442
RAF activation,R-HSA-5673000
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
Semaphorin interactions,R-HSA-373755
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,R-HSA-399955
Sema3A PAK dependent Axon repulsion,R-HSA-399954
CRMPs in Sema3A signaling,R-HSA-399956
Other semaphorin interactions,R-HSA-416700
Sema4D in semaphorin signaling,R-HSA-400685
Sema4D induced cell migration and growth-cone collapse,R-HSA-416572
Sema4D mediated inhibition of cell attachment and migration,R-HSA-416550
Transcriptional regulation of pluripotent stem cells,R-HSA-452723
"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",R-HSA-2892247
"POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation",R-HSA-2892245
LGI-ADAM interactions,R-HSA-5682910
Signaling by NODAL,R-HSA-1181150
Regulation of signaling by NODAL,R-HSA-1433617
Activation of HOX genes during differentiation,R-HSA-5619507
Activation of anterior HOX genes in hindbrain development during early embryogenesis,R-HSA-5617472
Vesicle-mediated transport,R-HSA-5653656
Membrane Trafficking,R-HSA-199991
trans-Golgi Network Vesicle Budding,R-HSA-199992
Clathrin derived vesicle budding,R-HSA-421837
Lysosome Vesicle Biogenesis,R-HSA-432720
Golgi Associated Vesicle Biogenesis,R-HSA-432722
Gap junction trafficking and regulation,R-HSA-157858
Gap junction trafficking,R-HSA-190828
Gap junction assembly,R-HSA-190861
Transport of connexins along the secretory pathway,R-HSA-190827
Transport of connexons to the plasma membrane,R-HSA-190872
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,R-HSA-190840
Oligomerization of connexins into connexons,R-HSA-190704
Gap junction degradation,R-HSA-190873
Formation of annular gap junctions,R-HSA-196025
Regulation of gap junction activity,R-HSA-191650
c-src mediated regulation of Cx43 function and closure of gap junctions,R-HSA-191647
Endosomal Sorting Complex Required For Transport (ESCRT),R-HSA-917729
ER to Golgi Anterograde Transport,R-HSA-199977
Cargo concentration in the ER,R-HSA-5694530
COPI-mediated anterograde transport,R-HSA-6807878
COPII (Coat Protein 2) Mediated Vesicle Transport,R-HSA-204005
Intra-Golgi and retrograde Golgi-to-ER traffic,R-HSA-6811442
Intra-Golgi traffic,R-HSA-6811438
Retrograde transport at the Trans-Golgi-Network,R-HSA-6811440
Golgi-to-ER retrograde transport,R-HSA-8856688
COPI-dependent Golgi-to-ER retrograde traffic,R-HSA-6811434
COPI-independent Golgi-to-ER retrograde traffic,R-HSA-6811436
Clathrin-mediated endocytosis,R-HSA-8856828
Cargo recognition for clathrin-mediated endocytosis,R-HSA-8856825
Translocation of GLUT4 to the plasma membrane,R-HSA-1445148
Binding and Uptake of Ligands by Scavenger Receptors,R-HSA-2173782
Scavenging by Class A Receptors,R-HSA-3000480
Scavenging by Class F Receptors,R-HSA-3000484
Scavenging of heme from plasma,R-HSA-2168880
Scavenging by Class B Receptors,R-HSA-3000471
Scavenging by Class H Receptors,R-HSA-3000497
Muscle contraction,R-HSA-397014
Striated Muscle Contraction,R-HSA-390522
Cardiac conduction,R-HSA-5576891
Physiological factors,R-HSA-5578768
Phase 2 - plateau phase,R-HSA-5576893
Phase 1 - inactivation of fast Na+ channels,R-HSA-5576894
Ion homeostasis,R-HSA-5578775
Phase 3 - rapid repolarisation,R-HSA-5576890
Phase 0 - rapid depolarisation,R-HSA-5576892
Phase 4 - resting membrane potential,R-HSA-5576886
Smooth Muscle Contraction,R-HSA-445355
Hemostasis,R-HSA-109582
"Platelet activation, signaling and aggregation",R-HSA-76002
Platelet Aggregation (Plug Formation),R-HSA-76009
Adrenaline signalling through Alpha-2 adrenergic receptor,R-HSA-392023
Integrin alphaIIb beta3 signaling,R-HSA-354192
GRB2:SOS provides linkage to MAPK signaling for Integrins,R-HSA-354194
p130Cas linkage to MAPK signaling for integrins,R-HSA-372708
Signal amplification,R-HSA-392518
Thromboxane signalling through TP receptor,R-HSA-428930
ADP signalling through P2Y purinoceptor 1,R-HSA-418592
ADP signalling through P2Y purinoceptor 12,R-HSA-392170
Thrombin signalling through proteinase activated receptors (PARs),R-HSA-456926
GPVI-mediated activation cascade,R-HSA-114604
Response to elevated platelet cytosolic Ca2+,R-HSA-76005
Disinhibition of SNARE formation,R-HSA-114516
Platelet degranulation,R-HSA-114608
Effects of PIP2 hydrolysis,R-HSA-114508
Arachidonate production from DAG,R-HSA-426048
GP1b-IX-V activation signalling,R-HSA-430116
Factors involved in megakaryocyte development and platelet production,R-HSA-983231
Kinesins,R-HSA-983189
Platelet homeostasis,R-HSA-418346
Nitric oxide stimulates guanylate cyclase,R-HSA-392154
cGMP effects,R-HSA-418457
Platelet sensitization by LDL,R-HSA-432142
Platelet calcium homeostasis,R-HSA-418360
Reduction of cytosolic Ca++ levels,R-HSA-418359
Elevation of cytosolic Ca2+ levels,R-HSA-139853
Prostacyclin signalling through prostacyclin receptor,R-HSA-392851
Platelet Adhesion to exposed collagen,R-HSA-75892
Formation of Fibrin Clot (Clotting Cascade),R-HSA-140877
Common Pathway of Fibrin Clot Formation,R-HSA-140875
Extrinsic Pathway of Fibrin Clot Formation,R-HSA-140834
Intrinsic Pathway of Fibrin Clot Formation,R-HSA-140837
Cell surface interactions at the vascular wall,R-HSA-202733
Basigin interactions,R-HSA-210991
Tie2 Signaling,R-HSA-210993
PECAM1 interactions,R-HSA-210990
Dissolution of Fibrin Clot,R-HSA-75205
Mitophagy,R-HSA-5205647
Pink/Parkin Mediated Mitophagy,R-HSA-5205685
Cellular responses to stress,R-HSA-2262752
Cellular response to heat stress,R-HSA-3371556
Regulation of HSF1-mediated heat shock response,R-HSA-3371453
HSF1 activation,R-HSA-3371511
HSF1-dependent transactivation,R-HSA-3371571
Attenuation phase,R-HSA-3371568
Cellular Senescence,R-HSA-2559583
DNA Damage/Telomere Stress Induced Senescence,R-HSA-2559586
Formation of Senescence-Associated Heterochromatin Foci (SAHF),R-HSA-2559584
Oncogene Induced Senescence,R-HSA-2559585
Oxidative Stress Induced Senescence,R-HSA-2559580
Senescence-Associated Secretory Phenotype (SASP),R-HSA-2559582
Detoxification of Reactive Oxygen Species,R-HSA-3299685
Macroautophagy,R-HSA-1632852
Cellular response to hypoxia,R-HSA-2262749
Regulation of Hypoxia-inducible Factor (HIF) by oxygen,R-HSA-1234174
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,R-HSA-1234176
Regulation of gene expression by Hypoxia-inducible Factor,R-HSA-1234158
Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha,R-HSA-1234162
Organelle biogenesis and maintenance,R-HSA-1852241
Mitochondrial translation,R-HSA-5368287
Mitochondrial translation elongation,R-HSA-5389840
Mitochondrial translation termination,R-HSA-5419276
Mitochondrial translation initiation,R-HSA-5368286
Mitochondrial biogenesis,R-HSA-1592230
Transcriptional activation of mitochondrial biogenesis,R-HSA-2151201
Activation of PPARGC1A (PGC-1alpha) by phosphorylation,R-HSA-2151209
Assembly of the primary cilium,R-HSA-5617833
Anchoring of the basal body to the plasma membrane,R-HSA-5620912
Intraflagellar transport,R-HSA-5620924
Cargo trafficking to the periciliary membrane,R-HSA-5620920
Trafficking of myristoylated proteins to the cilium,R-HSA-5624138
ARL13B-mediated ciliary trafficking of INPP5E,R-HSA-5624958
VxPx cargo-targeting to cilium,R-HSA-5620916
BBSome-mediated cargo-targeting to cilium,R-HSA-5620922
Chromatin organization,R-HSA-4839726
Chromatin modifying enzymes,R-HSA-3247509
RMTs methylate histone arginines,R-HSA-3214858
HATs acetylate histones,R-HSA-3214847
HDACs deacetylate histones,R-HSA-3214815
HDMs demethylate histones,R-HSA-3214842
PKMTs methylate histone lysines,R-HSA-3214841
Gene Expression,R-HSA-74160
Generic Transcription Pathway,R-HSA-212436
YAP1- and WWTR1 (TAZ)-stimulated gene expression,R-HSA-2032785
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,R-HSA-8864260
Activation of the TFAP2 (AP-2) family of transcription factors,R-HSA-8866907
Negative regulation of activity of TFAP2 (AP-2) family transcription factors,R-HSA-8866904
TFAP2 (AP-2) family regulates transcription of other transcription factors,R-HSA-8866906
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,R-HSA-8866910
TFAP2 (AP-2) family regulates transcription of cell cycle factors,R-HSA-8866911
TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,R-HSA-8869496
Nuclear Receptor transcription pathway,R-HSA-383280
Notch-HLH transcription pathway,R-HSA-350054
Transcriptional Regulation by TP53,R-HSA-3700989
TP53 Regulates Transcription of Cell Cycle Genes,R-HSA-6791312
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,R-HSA-6804114
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,R-HSA-6804115
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,R-HSA-6804116
TP53 Regulates Metabolic Genes,R-HSA-5628897
Regulation of TP53 Activity,R-HSA-5633007
Regulation of TP53 Activity through Association with Co-factors,R-HSA-6804759
Regulation of TP53 Activity through Acetylation,R-HSA-6804758
Regulation of TP53 Activity through Methylation,R-HSA-6804760
Regulation of TP53 Expression and Degradation,R-HSA-6806003
Regulation of TP53 Degradation,R-HSA-6804757
Regulation of TP53 Expression,R-HSA-6804754
Regulation of TP53 Activity through Phosphorylation,R-HSA-6804756
TP53 Regulates Transcription of Cell Death Genes,R-HSA-5633008
TP53 Regulates Transcription of Caspase Activators and Caspases,R-HSA-6803207
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,R-HSA-6803205
TP53 Regulates Transcription of Death Receptors and Ligands,R-HSA-6803211
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,R-HSA-6803204
TP53 Regulates Transcription of DNA Repair Genes,R-HSA-6796648
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,R-HSA-2173793
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,R-HSA-2173796
Downregulation of SMAD2/3:SMAD4 transcriptional activity,R-HSA-2173795
"RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription",R-HSA-504046
RNA Polymerase I Transcription,R-HSA-73864
RNA Polymerase I Chain Elongation,R-HSA-73777
RNA Polymerase I Promoter Clearance,R-HSA-73854
RNA Polymerase I Transcription Initiation,R-HSA-73762
RNA Polymerase I Promoter Opening,R-HSA-73728
RNA Polymerase I Promoter Escape,R-HSA-73772
RNA Polymerase I Transcription Termination,R-HSA-73863
Transcription from mitochondrial promoters,R-HSA-75944
Mitochondrial transcription termination,R-HSA-163316
Mitochondrial transcription initiation,R-HSA-163282
RNA Polymerase III Transcription,R-HSA-74158
RNA Polymerase III Abortive And Retractive Initiation,R-HSA-749476
RNA Polymerase III Transcription Termination,R-HSA-73980
RNA Polymerase III Chain Elongation,R-HSA-73780
RNA Polymerase III Transcription Initiation,R-HSA-76046
RNA Polymerase III Transcription Initiation From Type 2 Promoter,R-HSA-76066
RNA Polymerase III Transcription Initiation From Type 1 Promoter,R-HSA-76061
RNA Polymerase III Transcription Initiation From Type 3 Promoter,R-HSA-76071
Processing of Capped Intron-Containing Pre-mRNA,R-HSA-72203
Transport of Mature Transcript to Cytoplasm,R-HSA-72202
Transport of Mature mRNA derived from an Intron-Containing Transcript,R-HSA-159236
Transport of Mature mRNAs Derived from Intronless Transcripts,R-HSA-159234
Transport of the SLBP Dependant Mature mRNA,R-HSA-159230
Transport of Mature mRNA Derived from an Intronless Transcript,R-HSA-159231
Transport of the SLBP independent Mature mRNA,R-HSA-159227
mRNA Splicing,R-HSA-72172
mRNA Splicing - Major Pathway,R-HSA-72163
mRNA Splicing - Minor Pathway,R-HSA-72165
mRNA 3'-end processing,R-HSA-72187
mRNA Editing,R-HSA-75072
mRNA Editing: C to U Conversion,R-HSA-72200
Formation of the Editosome,R-HSA-75094
mRNA Editing: A to I Conversion,R-HSA-75064
Formation of editosomes by ADAR proteins,R-HSA-77042
C6 deamination of adenosine,R-HSA-75102
Deadenylation-dependent mRNA decay,R-HSA-429914
mRNA decay by 5' to 3' exoribonuclease,R-HSA-430039
mRNA decay by 3' to 5' exoribonuclease,R-HSA-429958
Deadenylation of mRNA,R-HSA-429947
tRNA Aminoacylation,R-HSA-379724
Mitochondrial tRNA aminoacylation,R-HSA-379726
Cytosolic tRNA aminoacylation,R-HSA-379716
rRNA processing,R-HSA-72312
rRNA processing in the mitochondrion,R-HSA-8868766
rRNA modification in the mitochondrion,R-HSA-6793080
rRNA processing in the nucleus and cytosol,R-HSA-8868773
rRNA modification in the nucleus and cytosol,R-HSA-6790901
Major pathway of rRNA processing in the nucleolus and cytosol,R-HSA-6791226
mRNA Capping,R-HSA-72086
Nonsense-Mediated Decay (NMD),R-HSA-927802
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),R-HSA-975957
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),R-HSA-975956
RNA Polymerase II Transcription,R-HSA-73857
RNA Polymerase II Transcription Termination,R-HSA-73856
Cleavage of Growing Transcript in the Termination Region,R-HSA-109688
RNA Polymerase II Pre-transcription Events,R-HSA-674695
RNA Polymerase II Transcription Initiation And Promoter Clearance,R-HSA-76042
RNA Polymerase II Promoter Escape,R-HSA-73776
RNA Polymerase II Transcription Initiation,R-HSA-75953
RNA Polymerase II Transcription Elongation,R-HSA-75955
Formation of RNA Pol II elongation complex,R-HSA-112382
Formation of the Early Elongation Complex,R-HSA-113418
RNA Pol II CTD phosphorylation and interaction with CE,R-HSA-77075
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,R-HSA-73779
Gene Silencing by RNA,R-HSA-211000
MicroRNA (miRNA) biogenesis,R-HSA-203927
PIWI-interacting RNA (piRNA) biogenesis,R-HSA-5601884
Transcriptional regulation by small RNAs,R-HSA-5578749
Post-transcriptional silencing by small RNAs,R-HSA-426496
Small interfering RNA (siRNA) biogenesis,R-HSA-426486
RNA polymerase II transcribes snRNA genes,R-HSA-6807505
Processing of Capped Intronless Pre-mRNA,R-HSA-75067
Processing of Intronless Pre-mRNAs,R-HSA-77595
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,R-HSA-77588
SLBP independent Processing of Histone Pre-mRNAs,R-HSA-111367
Regulation of mRNA stability by proteins that bind AU-rich elements,R-HSA-450531
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,R-HSA-450385
"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",R-HSA-450513
HuR (ELAVL1) binds and stabilizes mRNA,R-HSA-450520
KSRP (KHSRP) binds and destabilizes mRNA,R-HSA-450604
AUF1 (hnRNP D0) binds and destabilizes mRNA,R-HSA-450408
tRNA processing,R-HSA-72306
tRNA processing in the nucleus,R-HSA-6784531
tRNA modification in the nucleus and cytosol,R-HSA-6782315
Synthesis of wybutosine at G37 of tRNA(Phe),R-HSA-6782861
tRNA modification in the mitochondrion,R-HSA-6787450
tRNA processing in the mitochondrion,R-HSA-6785470
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,R-HSA-428359
Metabolism of non-coding RNA,R-HSA-194441
snRNP Assembly,R-HSA-191859
Translation,R-HSA-72766
Eukaryotic Translation Termination,R-HSA-72764
Eukaryotic Translation Initiation,R-HSA-72613
L13a-mediated translational silencing of Ceruloplasmin expression,R-HSA-156827
Cap-dependent Translation Initiation,R-HSA-72737
"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",R-HSA-72662
Translation initiation complex formation,R-HSA-72649
Recycling of eIF2:GDP,R-HSA-72731
"Formation of the ternary complex, and subsequently, the 43S complex",R-HSA-72695
Ribosomal scanning and start codon recognition,R-HSA-72702
GTP hydrolysis and joining of the 60S ribosomal subunit,R-HSA-72706
Formation of a pool of free 40S subunits,R-HSA-72689
SRP-dependent cotranslational protein targeting to membrane,R-HSA-1799339
Eukaryotic Translation Elongation,R-HSA-156842
Peptide chain elongation,R-HSA-156902
Epigenetic regulation of gene expression,R-HSA-212165
PRC2 methylates histones and DNA,R-HSA-212300
"TET1,2,3 and TDG demethylate DNA",R-HSA-5221030
DNA methylation,R-HSA-5334118
Positive epigenetic regulation of rRNA expression,R-HSA-5250913
B-WICH complex positively regulates rRNA expression,R-HSA-5250924
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,R-HSA-427389
Negative epigenetic regulation of rRNA expression,R-HSA-5250941
NoRC negatively regulates rRNA expression,R-HSA-427413
SIRT1 negatively regulates rRNA Expression,R-HSA-427359
Transmembrane transport of small molecules,R-HSA-382551
Iron uptake and transport,R-HSA-917937
Transferrin endocytosis and recycling,R-HSA-917977
Ion channel transport,R-HSA-983712
Ligand-gated ion channel transport,R-HSA-975298
Ion transport by P-type ATPases,R-HSA-936837
Stimuli-sensing channels,R-HSA-2672351
TRP channels,R-HSA-3295583
SLC-mediated transmembrane transport,R-HSA-425407
"Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds",R-HSA-425366
"Sodium-coupled sulphate, di- and tri-carboxylate transporters",R-HSA-433137
Proton-coupled monocarboxylate transport,R-HSA-433692
Metal ion SLC transporters,R-HSA-425410
Zinc transporters,R-HSA-435354
Zinc efflux and compartmentalization by the SLC30 family,R-HSA-435368
Zinc influx into cells by the SLC39 gene family,R-HSA-442380
Na+/Cl- dependent neurotransmitter transporters,R-HSA-442660
Organic cation/anion/zwitterion transport,R-HSA-549132
Organic cation transport,R-HSA-549127
Organic anion transport,R-HSA-561048
Na+-dependent glucose transporters,R-HSA-428808
Inositol transporters,R-HSA-429593
Facilitative Na+-independent glucose transporters,R-HSA-428790
Class II GLUTs,R-HSA-428776
Rhesus glycoproteins mediate ammonium transport.,R-HSA-444411
"Transport of vitamins, nucleosides, and related molecules",R-HSA-425397
Transport of organic anions,R-HSA-879518
Transport of fatty acids,R-HSA-804914
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,R-HSA-83936
Transport of nucleotide sugars,R-HSA-727802
Hexose transport,R-HSA-189200
Glucose transport,R-HSA-70153
Regulation of Glucokinase by Glucokinase Regulatory Protein,R-HSA-170822
Transport of inorganic cations/anions and amino acids/oligopeptides,R-HSA-425393
Sodium/Proton exchangers,R-HSA-425986
Amino acid transport across the plasma membrane,R-HSA-352230
Multifunctional anion exchangers,R-HSA-427601
Sodium-coupled phosphate cotransporters,R-HSA-427652
Type II Na+/Pi cotransporters,R-HSA-427589
Cation-coupled Chloride cotransporters,R-HSA-426117
Proton/oligopeptide cotransporters,R-HSA-427975
Organic anion transporters,R-HSA-428643
Proton-coupled neutral amino acid transporters,R-HSA-428559
Sodium/Calcium exchangers,R-HSA-425561
Bicarbonate transporters,R-HSA-425381
Miscellaneous transport and binding events,R-HSA-5223345
ABC-family proteins mediated transport,R-HSA-382556
Mitochondrial ABC transporters,R-HSA-1369007
ABC transporters in lipid homeostasis,R-HSA-1369062
Aquaporin-mediated transport,R-HSA-445717
Passive transport by Aquaporins,R-HSA-432047
Transport of glycerol from adipocytes to the liver by Aquaporins,R-HSA-432030
Vasopressin regulates renal water homeostasis via Aquaporins,R-HSA-432040
Circadian Clock,R-HSA-400253
RORA activates gene expression,R-HSA-1368082
"BMAL1:CLOCK,NPAS2 activates circadian gene expression",R-HSA-1368108
NR1D1 (REV-ERBA) represses gene expression,R-HSA-1368071
Metabolism of proteins,R-HSA-392499
Amyloid fiber formation,R-HSA-977225
Protein repair,R-HSA-5676934
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),R-HSA-381426
Translation,R-HSA-72766
Eukaryotic Translation Termination,R-HSA-72764
SRP-dependent cotranslational protein targeting to membrane,R-HSA-1799339
Eukaryotic Translation Initiation,R-HSA-72613
Cap-dependent Translation Initiation,R-HSA-72737
Formation of a pool of free 40S subunits,R-HSA-72689
"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",R-HSA-72662
Translation initiation complex formation,R-HSA-72649
Recycling of eIF2:GDP,R-HSA-72731
GTP hydrolysis and joining of the 60S ribosomal subunit,R-HSA-72706
Ribosomal scanning and start codon recognition,R-HSA-72702
"Formation of the ternary complex, and subsequently, the 43S complex",R-HSA-72695
L13a-mediated translational silencing of Ceruloplasmin expression,R-HSA-156827
Eukaryotic Translation Elongation,R-HSA-156842
Peptide chain elongation,R-HSA-156902
Protein folding,R-HSA-391251
Chaperonin-mediated protein folding,R-HSA-390466
Association of TriC/CCT with target proteins during biosynthesis,R-HSA-390471
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,R-HSA-389958
Prefoldin mediated transfer of substrate  to CCT/TriC,R-HSA-389957
Folding of actin by CCT/TriC,R-HSA-390450
Formation of tubulin folding intermediates by CCT/TriC,R-HSA-389960
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,R-HSA-6814122
Post-chaperonin tubulin folding pathway,R-HSA-389977
Peptide hormone metabolism,R-HSA-2980736
Insulin processing,R-HSA-264876
Metabolism of Angiotensinogen to Angiotensins,R-HSA-2022377
Peptide hormone biosynthesis,R-HSA-209952
Glycoprotein hormones,R-HSA-209822
"Incretin synthesis, secretion, and inactivation",R-HSA-400508
"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)",R-HSA-400511
"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)",R-HSA-381771
"Synthesis, secretion, and deacylation of Ghrelin",R-HSA-422085
Unfolded Protein Response (UPR),R-HSA-381119
IRE1alpha activates chaperones,R-HSA-381070
XBP1(S) activates chaperone genes,R-HSA-381038
ATF6-alpha activates chaperones,R-HSA-381033
ATF6-alpha activates chaperone genes,R-HSA-381183
PERK regulates gene expression,R-HSA-381042
ATF4 activates genes,R-HSA-380994
Mitochondrial protein import,R-HSA-1268020
Surfactant metabolism,R-HSA-5683826
Post-translational protein modification,R-HSA-597592
Asparagine N-linked glycosylation,R-HSA-446203
N-glycan trimming in the ER and Calnexin/Calreticulin cycle,R-HSA-532668
Calnexin/calreticulin cycle,R-HSA-901042
ER Quality Control Compartment (ERQC),R-HSA-901032
Transport to the Golgi and subsequent modification,R-HSA-948021
N-glycan trimming and elongation in the cis-Golgi,R-HSA-964739
"Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2",R-HSA-964827
ER to Golgi Anterograde Transport,R-HSA-199977
COPI-mediated anterograde transport,R-HSA-6807878
Cargo concentration in the ER,R-HSA-5694530
COPII (Coat Protein 2) Mediated Vesicle Transport,R-HSA-204005
N-glycan antennae elongation in the medial/trans-Golgi,R-HSA-975576
Reactions specific to the hybrid N-glycan synthesis pathway,R-HSA-975574
Reactions specific to the complex N-glycan synthesis pathway,R-HSA-975578
N-Glycan antennae elongation,R-HSA-975577
"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",R-HSA-446193
Synthesis of substrates in N-glycan biosythesis,R-HSA-446219
Synthesis of dolichyl-phosphate-glucose,R-HSA-480985
GDP-fucose biosynthesis,R-HSA-6787639
Synthesis of GDP-mannose,R-HSA-446205
Synthesis of dolichyl-phosphate mannose,R-HSA-162699
Sialic acid metabolism,R-HSA-4085001
Synthesis of UDP-N-acetyl-glucosamine,R-HSA-446210
Synthesis of Dolichyl-phosphate,R-HSA-446199
"Gamma carboxylation, hypusine formation and arylsulfatase activation",R-HSA-163841
The activation of arylsulfatases,R-HSA-1663150
Hypusine synthesis from eIF5A-lysine,R-HSA-204626
Synthesis of diphthamide-EEF2,R-HSA-5358493
"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",R-HSA-159854
Gamma-carboxylation of protein precursors,R-HSA-159740
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus,R-HSA-159763
Removal of aminoterminal propeptides from gamma-carboxylated proteins,R-HSA-159782
SUMOylation,R-HSA-2990846
Processing and activation of SUMO,R-HSA-3215018
SUMO is conjugated to E1 (UBA2:SAE1),R-HSA-3065676
"SUMO is transferred from E1 to E2 (UBE2I, UBC9)",R-HSA-3065678
SUMO is proteolytically processed,R-HSA-3065679
SUMO E3 ligases SUMOylate target proteins,R-HSA-3108232
SUMOylation of DNA replication proteins,R-HSA-4615885
SUMOylation of transcription factors,R-HSA-3232118
SUMOylation of RNA binding proteins,R-HSA-4570464
SUMOylation of chromatin organization proteins,R-HSA-4551638
SUMOylation of DNA damage response and repair proteins,R-HSA-3108214
O-linked glycosylation,R-HSA-5173105
O-glycosylation of TSR domain-containing proteins,R-HSA-5173214
O-linked glycosylation of mucins,R-HSA-913709
Termination of O-glycan biosynthesis,R-HSA-977068
Deubiquitination,R-HSA-5688426
UCH proteinases,R-HSA-5689603
Metalloprotease DUBs,R-HSA-5689901
Ovarian tumor domain proteases,R-HSA-5689896
Josephin domain DUBs,R-HSA-5689877
Ub-specific processing proteases,R-HSA-5689880
Post-translational modification: synthesis of GPI-anchored proteins,R-HSA-163125
Attachment of GPI anchor to uPAR,R-HSA-162791
Synthesis of dolichyl-phosphate mannose,R-HSA-162699
Synthesis of glycosylphosphatidylinositol (GPI),R-HSA-162710
Programmed Cell Death,R-HSA-5357801
Apoptosis,R-HSA-109581
Intrinsic Pathway for Apoptosis,R-HSA-109606
Activation and oligomerization of BAK protein,R-HSA-111452
"Activation, translocation and oligomerization of BAX",R-HSA-114294
Release of apoptotic factors from the mitochondria,R-HSA-111457
Activation of BH3-only proteins,R-HSA-114452
Activation of NOXA and translocation to mitochondria,R-HSA-111448
Activation of BAD and translocation to mitochondria,R-HSA-111447
Activation of PUMA and translocation to mitochondria,R-HSA-139915
Activation of BMF and translocation to mitochondria,R-HSA-139910
Activation of BIM and translocation to mitochondria,R-HSA-111446
BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members,R-HSA-111453
Apoptotic factor-mediated response,R-HSA-111471
Cytochrome c-mediated apoptotic response,R-HSA-111461
Formation of apoptosome,R-HSA-111458
Activation of caspases through apoptosome-mediated cleavage,R-HSA-111459
SMAC-mediated apoptotic response,R-HSA-111469
SMAC binds to IAPs,R-HSA-111463
SMAC-mediated dissociation of IAP:caspase complexes,R-HSA-111464
"Activation, myristolyation of BID and translocation to mitochondria",R-HSA-75108
Regulation of Apoptosis,R-HSA-169911
Regulation of activated PAK-2p34 by proteasome mediated degradation,R-HSA-211733
Regulation of PAK-2p34 activity by PS-GAP/RHG10,R-HSA-211728
Caspase activation via extrinsic apoptotic signalig pathway,R-HSA-5357769
Ligand-dependent caspase activation,R-HSA-140534
Regulation by c-FLIP,R-HSA-3371378
Dimerization of procaspase-8,R-HSA-69416
Ligand-independent caspase activation via DCC,R-HSA-418889
Apoptotic execution  phase,R-HSA-75153
Stimulation of the cell death response by PAK-2p34,R-HSA-211736
Apoptosis induced DNA fragmentation,R-HSA-140342
Activation of DNA fragmentation factor,R-HSA-211227
Apoptotic cleavage of cellular proteins,R-HSA-111465
Caspase-mediated cleavage of cytoskeletal proteins,R-HSA-264870
Apoptotic cleavage of cell adhesion  proteins,R-HSA-351906
Breakdown of the nuclear lamina,R-HSA-352238
Regulated Necrosis,R-HSA-5218859
RIPK1-mediated regulated necrosis,R-HSA-5213460
Regulation of necroptotic cell death,R-HSA-5675482
CASP8 activity is inhibited,R-HSA-5218900
Extracellular matrix organization,R-HSA-1474244
Fibronectin matrix formation,R-HSA-1566977
Elastic fibre formation,R-HSA-1566948
Molecules associated with elastic fibres,R-HSA-2129379
Laminin interactions,R-HSA-3000157
Non-integrin membrane-ECM interactions,R-HSA-3000171
Syndecan interactions,R-HSA-3000170
Integrin cell surface interactions,R-HSA-216083
Degradation of the extracellular matrix,R-HSA-1474228
Activation of Matrix Metalloproteinases,R-HSA-1592389
Collagen degradation,R-HSA-1442490
ECM proteoglycans,R-HSA-3000178
Collagen formation,R-HSA-1474290
Assembly of collagen fibrils and other multimeric structures,R-HSA-2022090
Crosslinking of collagen fibrils,R-HSA-2243919
Anchoring fibril formation,R-HSA-2214320
Collagen biosynthesis and modifying enzymes,R-HSA-1650814
DNA Replication,R-HSA-69306
Synthesis of DNA,R-HSA-69239
Switching of origins to a post-replicative state,R-HSA-69052
Orc1 removal from chromatin,R-HSA-68949
CDK-mediated phosphorylation and removal of Cdc6,R-HSA-69017
DNA strand elongation,R-HSA-69190
Unwinding of DNA,R-HSA-176974
Lagging Strand Synthesis,R-HSA-69186
Processive synthesis on the lagging strand,R-HSA-69183
Removal of the Flap Intermediate,R-HSA-69166
Polymerase switching,R-HSA-69091
Leading Strand Synthesis,R-HSA-69109
Polymerase switching,R-HSA-69091
DNA replication initiation,R-HSA-68952
M/G1 Transition,R-HSA-68874
DNA Replication Pre-Initiation,R-HSA-69002
Activation of the pre-replicative complex,R-HSA-68962
Assembly of the pre-replicative complex,R-HSA-68867
CDT1 association with the CDC6:ORC:origin complex,R-HSA-68827
Assembly of the ORC complex at the origin of replication,R-HSA-68616
CDC6 association with the ORC:origin complex,R-HSA-68689
Regulation of DNA replication,R-HSA-69304
Association of licensing factors with the pre-replicative complex,R-HSA-69298
Removal of licensing factors from origins,R-HSA-69300
Orc1 removal from chromatin,R-HSA-68949
CDK-mediated phosphorylation and removal of Cdc6,R-HSA-69017
Disease,R-HSA-1643685
Diseases of metabolism,R-HSA-5668914
Diseases of carbohydrate metabolism,R-HSA-5663084
Glycogen storage diseases,R-HSA-3229121
Glycogen storage disease type Ia (G6PC),R-HSA-3274531
Severe congenital neutropenia type 4 (G6PC3),R-HSA-3282872
Glycogen storage disease type IV (GBE1),R-HSA-3878781
Glycogen storage disease type 0 (liver GYS2),R-HSA-3858516
Glycogen storage disease type 0 (muscle GYS1),R-HSA-3828062
Myoclonic epilepsy of Lafora,R-HSA-3785653
Glycogen storage disease type Ib (SLC37A4),R-HSA-3229133
Glycogen storage disease type II (GAA),R-HSA-5357609
Glycogen storage disease type XV (GYG1),R-HSA-3814836
Essential pentosuria,R-HSA-5662853
Mucopolysaccharidoses,R-HSA-2206281
MPS IV - Morquio syndrome A,R-HSA-2206290
MPS IX - Natowicz syndrome,R-HSA-2206280
MPS IIIB - Sanfilippo syndrome B,R-HSA-2206282
MPS IIIC - Sanfilippo syndrome C,R-HSA-2206291
MPS I - Hurler syndrome,R-HSA-2206302
MPS IV - Morquio syndrome B,R-HSA-2206308
MPS IIIA - Sanfilippo syndrome A,R-HSA-2206307
MPS VII - Sly syndrome,R-HSA-2206292
MPS II - Hunter syndrome,R-HSA-2206296
MPS IIID - Sanfilippo syndrome D,R-HSA-2206305
MPS VI - Maroteaux-Lamy syndrome,R-HSA-2206285
Essential fructosuria,R-HSA-5657562
Hereditary fructose intolerance,R-HSA-5657560
Intestinal saccharidase deficiencies,R-HSA-5659898
Pentose phosphate pathway disease,R-HSA-6791465
"TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P",R-HSA-6791055
RPIA deficiency: failed conversion of RU5P to R5P,R-HSA-6791461
"TALDO1 deficiency: failed conversion of  Fru(6)P, E4P to SH7P, GA3P",R-HSA-6791462
RPIA deficiency: failed conversion of R5P to RU5P,R-HSA-5659996
Defects in vitamin and cofactor metabolism,R-HSA-3296482
Defects in biotin (Btn) metabolism,R-HSA-3323169
Defective HLCS causes multiple carboxylase deficiency,R-HSA-3371599
Defective BTD causes biotidinase deficiency,R-HSA-3371598
Defects in cobalamin (B12) metabolism,R-HSA-3296469
Defective MTR causes methylmalonic aciduria and homocystinuria type cblG,R-HSA-3359469
Defective MUT causes methylmalonic aciduria mut type,R-HSA-3359478
Defective CD320 causes methylmalonic aciduria,R-HSA-3359485
Defective TCN2 causes hereditary megaloblastic anemia,R-HSA-3359454
Defective MMAB causes methylmalonic aciduria type cblB,R-HSA-3359471
Defective MMAA causes methylmalonic aciduria type cblA,R-HSA-3359475
Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE,R-HSA-3359467
Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC,R-HSA-3359474
"Defective ABCD4 causes methylmalonic aciduria and homocystinuria, cblj type (MAHCJ)",R-HSA-5683329
Defective LMBRD1 causes methylmalonic aciduria and homocystinuria type cblF,R-HSA-3359458
Defective CUBN causes hereditary megaloblastic anemia 1,R-HSA-3359463
Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD,R-HSA-3359473
Defective AMN causes hereditary megaloblastic anemia 1,R-HSA-3359462
Defective GIF causes intrinsic factor deficiency,R-HSA-3359457
Diseases associated with surfactant metabolism,R-HSA-5687613
Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS),R-HSA-5688031
Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM),R-HSA-5687583
Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF),R-HSA-5687868
Defective ABCA3 causes pulmonary surfactant metabolism dysfunction 3 (SMDP3),R-HSA-5688399
Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5),R-HSA-5688849
Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS),R-HSA-5688354
Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4),R-HSA-5688890
Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate,R-HSA-2978092
Metabolic disorders of biological oxidation enzymes,R-HSA-5579029
Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX),R-HSA-5578996
"Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)",R-HSA-5579005
Defective SLC35D1 causes Schneckenbecken dysplasia (SCHBCKD),R-HSA-5579020
Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD),R-HSA-5578999
Defective MAOA causes Brunner syndrome (BRUNS),R-HSA-5579012
Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A),R-HSA-5579014
Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA),R-HSA-5579015
Defective UGT1A1 causes hyperbilirubinemia,R-HSA-5579002
Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5),R-HSA-5579028
Defective GSS causes Glutathione synthetase deficiency (GSS deficiency),R-HSA-5579006
Defective MAT1A causes Methionine adenosyltransferase deficiency (MATD),R-HSA-5579024
Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4),R-HSA-5579004
Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD),R-HSA-5579032
Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD),R-HSA-5579031
Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3),R-HSA-5579021
Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency),R-HSA-5579009
"Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)",R-HSA-5579011
Defective OPLAH causes 5-oxoprolinase deficiency (OPLAHD),R-HSA-5578998
Defective FMO3 causes Trimethylaminuria (TMAU),R-HSA-5579019
Defective UGT1A4 causes hyperbilirubinemia,R-HSA-5579016
Defective CYP19A1 causes Aromatase excess syndrome (AEXS),R-HSA-5579030
Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4),R-HSA-5579017
"Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)",R-HSA-5579013
Defective ACY1 causes encephalopathy,R-HSA-5579007
Defective GGT1 causes Glutathionuria (GLUTH),R-HSA-5579022
Defective TPMT causes Thiopurine S-methyltransferase deficiency (TPMT deficiency),R-HSA-5578995
Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B),R-HSA-5579027
"Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)",R-HSA-5579010
"Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)",R-HSA-5579026
Defective AHCY causes Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD),R-HSA-5578997
Defective CYP1B1 causes Glaucoma,R-HSA-5579000
Phenylketonuria,R-HSA-2160456
Disorders of transmembrane transporters,R-HSA-5619115
ABC transporter disorders,R-HSA-5619084
Defective ABCB11 causes progressive familial intrahepatic cholestasis 2 and benign recurrent intrahepatic cholestasis 2,R-HSA-5678520
"Defective ABCB4 causes progressive familial intrahepatic cholestasis 3, intrahepatic cholestasis of pregnancy 3 and gallbladder disease 1",R-HSA-5678771
Defective ABCA12 causes autosomal recessive congenital ichthyosis type 4B,R-HSA-5682294
"Defective ABCD4 causes methylmalonic aciduria and homocystinuria, cblj type (MAHCJ)",R-HSA-5683329
Defective ABCB6 causes isolated colobomatous microphthalmia 7 (MCOPCB7),R-HSA-5683371
Defective ABCA1 causes Tangier disease,R-HSA-5682113
Defective ABCC8 can cause hypoglycemias and hyperglycemias,R-HSA-5683177
Defective ABCC2 causes Dubin-Johnson syndrome,R-HSA-5679001
Defective ABCD1 causes adrenoleukodystrophy (ALD),R-HSA-5684045
Defective ABCC6 causes pseudoxanthoma elasticum (PXE),R-HSA-5690338
Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3),R-HSA-5683678
Defective CFTR causes cystic fibrosis,R-HSA-5678895
"Defective ABCC9 causes dilated cardiomyopathy 10, familial atrial fibrillation 12 and hypertrichotic osteochondrodysplasia",R-HSA-5678420
Defective ABCG5 causes sitosterolemia,R-HSA-5679096
Defective ABCG8 causes gallbladder disease 4 and sitosterolemia,R-HSA-5679090
SLC transporter disorders,R-HSA-5619102
Defective SLC26A2 causes chondrodysplasias,R-HSA-3560792
Defective SLC33A1 causes spastic paraplegia 42 (SPG42),R-HSA-5619061
Defective SLC7A9 causes cystinuria (CSNU),R-HSA-5660883
Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1),R-HSA-5619043
"Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1)",R-HSA-5619048
Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA),R-HSA-5619067
Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1),R-HSA-5619111
Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS),R-HSA-5619063
Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1),R-HSA-5619040
Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG),R-HSA-5619101
Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F),R-HSA-5619037
Defective SLC6A19 causes Hartnup disorder (HND),R-HSA-5659735
Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM),R-HSA-5656364
"Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)",R-HSA-5619110
"Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)",R-HSA-5619058
Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC),R-HSA-5619107
Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT),R-HSA-5619070
"Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN)",R-HSA-5619039
Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1),R-HSA-5619066
"Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS)",R-HSA-5619083
Defective SLC17A5 causes Salla disease (SD) and ISSD,R-HSA-5619035
"Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)",R-HSA-5661182
"Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ)",R-HSA-5619088
Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria,R-HSA-5659729
Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP),R-HSA-5619053
Defective SLC26A4 causes Pendred syndrome (PDS),R-HSA-5619046
Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A),R-HSA-5658471
"Defective SLC9A6 causes  X-linked, syndromic mental retardation,, Christianson type (MRXSCH)",R-HSA-5619092
Defective SLC2A9 causes hypouricemia renal 2 (RHUC2),R-HSA-5619047
Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN),R-HSA-5619042
Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M),R-HSA-5619072
Defective SLC5A2 causes renal glucosuria (GLYS1),R-HSA-5658208
Defective SLC6A2 causes orthostatic intolerance (OI),R-HSA-5619109
Defective SLC6A5 causes hyperekplexia 3 (HKPX3),R-HSA-5619089
Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS),R-HSA-5619098
Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D),R-HSA-5619077
Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1),R-HSA-5619096
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages),R-HSA-5619049
"Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4),  distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA)",R-HSA-5619050
"Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA)",R-HSA-5619054
Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C),R-HSA-5619078
Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F),R-HSA-5663020
Defective SLC1A3 causes episodic ataxia 6 (EA6),R-HSA-5619062
Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG),R-HSA-5660686
Defective SLC9A9 causes autism 16 (AUTS16),R-HSA-5619052
Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG),R-HSA-5619041
Defective GCK causes maturity-onset diabetes of the young 2 (MODY2),R-HSA-5619073
Defective SLC12A3 causes Gitelman syndrome (GS),R-HSA-5619087
Defective SLC6A19 causes Hartnup disorder (HND),R-HSA-5619044
Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25),R-HSA-5619076
Defective CP causes aceruloplasminemia (ACERULOP),R-HSA-5619060
Defective SLC12A1 causes Bartter syndrome 1 (BS1),R-HSA-5619104
Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS),R-HSA-5660724
Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A),R-HSA-5619114
Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH),R-HSA-5619097
Defective SLC2A10 causes arterial tortuosity syndrome (ATS),R-HSA-5619068
Variant SLC6A14 may confer susceptibility towards obesity,R-HSA-5619094
Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6),R-HSA-5619036
Defective SLC3A1 causes cystinuria (CSNU),R-HSA-5619113
Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1),R-HSA-5619085
Defective SLC7A7 causes lysinuric protein intolerance (LPI),R-HSA-5660862
Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS),R-HSA-5619108
Defective HK1 causes hexokinase deficiency (HK deficiency),R-HSA-5619056
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum),R-HSA-5655799
Defective SLC22A12 causes renal hypouricemia 1 (RHUC1),R-HSA-5619071
Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI),R-HSA-5619055
Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS),R-HSA-5619081
Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM),R-HSA-5619045
Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria,R-HSA-5619079
Defective AVP causes neurohypophyseal diabetes insipidus (NDI),R-HSA-5619099
"Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2)",R-HSA-5619095
Diseases of glycosylation,R-HSA-3781865
Diseases associated with glycosaminoglycan metabolism,R-HSA-3560782
"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",R-HSA-3656253
Defective CHST3 causes SEDCJD,R-HSA-3595172
Defective EXT2 causes exostoses 2,R-HSA-3656237
Defective PAPSS2 causes SEMD-PA,R-HSA-3560796
Defective ST3GAL3 causes MCT12 and EIEE15,R-HSA-3656243
Defective B3GAT3 causes JDSSDHD,R-HSA-3560801
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),R-HSA-3656244
"Defective B4GALT7 causes EDS, progeroid type",R-HSA-3560783
"Defective CHST14 causes EDS, musculocontractural type",R-HSA-3595174
Defective CHST6 causes MCDC1,R-HSA-3656225
Defective SLC26A2 causes chondrodysplasias,R-HSA-3560792
Defective B3GALT6 causes EDSP2 and SEMDJL1,R-HSA-4420332
Defective CHSY1 causes TPBS,R-HSA-3595177
Diseases associated with N-glycosylation of proteins,R-HSA-3781860
Defective ALG2 causes ALG2-CDG (CDG-1i),R-HSA-4549349
Defective MOGS causes MOGS-CDG (CDG-2b),R-HSA-4793954
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),R-HSA-4793953
Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2,R-HSA-4549356
Defective ALG3 causes ALG3-CDG (CDG-1d),R-HSA-4720475
Defective ALG12 causes ALG12-CDG (CDG-1g),R-HSA-4720489
Defective RFT1 causes RFT1-CDG (CDG-1n),R-HSA-4570571
Defective MPDU1 causes MPDU1-CDG (CDG-1f),R-HSA-4687000
Defective ALG8 causes ALG8-CDG (CDG-1h),R-HSA-4724325
Defective ALG1 causes ALG1-CDG (CDG-1k),R-HSA-4549380
Defective MAN1B1 causes MRT15,R-HSA-4793950
Defective MGAT2 causes MGAT2-CDG (CDG-2a),R-HSA-4793952
Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS),R-HSA-5633231
Defective ALG11 causes ALG11-CDG (CDG-1p),R-HSA-4551295
Defective ALG6 causes ALG6-CDG (CDG-1c),R-HSA-4724289
Defective ALG9 causes ALG9-CDG (CDG-1l),R-HSA-4720454
Diseases associated with O-glycosylation of proteins,R-HSA-3906995
Defective GALNT12 causes colorectal cancer 1 (CRCS1),R-HSA-5083636
"Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2",R-HSA-5083629
Defective LARGE causes MDDGA6 and MDDGB6,R-HSA-5083627
Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC),R-HSA-5083625
Defective B3GALTL causes Peters-plus syndrome (PpS),R-HSA-5083635
Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS),R-HSA-5083632
Defective LFNG causes SCDO3,R-HSA-5083630
"Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3",R-HSA-5083628
"Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1",R-HSA-5083633
Diseases associated with glycosylation precursor biosynthesis,R-HSA-5609975
Defective PGM1 causes PGM1-CDG (CDG1t),R-HSA-5609974
Defective PMM2 causes PMM2-CDG (CDG-1a),R-HSA-4043911
Defective GALK1 can cause Galactosemia II (GALCT2),R-HSA-5609976
Defective GFPT1 causes CMSTA1,R-HSA-4085023
Defective DPM2 causes DPM2-CDG (CDG-1u),R-HSA-4719377
Defective DHDDS causes retinitis pigmentosa 59,R-HSA-4755609
Defective MPI causes MPI-CDG (CDG-1b),R-HSA-4043916
Defective GALT can cause Galactosemia,R-HSA-5609978
"Defective GNE causes sialuria, Nonaka myopathy and inclusion body myopathy 2",R-HSA-4085011
Defective DPM1 causes DPM1-CDG (CDG-1e),R-HSA-4717374
Defective DPM3 causes DPM3-CDG (CDG-1o),R-HSA-4719360
Defective NEU1 causes sialidosis,R-HSA-4341670
Defective DOLK causes DOLK-CDG (CDG-1m),R-HSA-4755583
Defective GALE can cause Epimerase-deficiency galactosemia (EDG),R-HSA-5609977
Defective SRD5A3 causes SRD5A3-CDG (CDG-1q) and KHRZ,R-HSA-4755579
Diseases of signal transduction,R-HSA-5663202
Signaling by FGFR in disease,R-HSA-1226099
Signaling by FGFR1 in disease,R-HSA-5655302
FGFR1 mutant receptor activation,R-HSA-1839124
Signaling by FGFR1 amplification mutants,R-HSA-1839120
Signaling by plasma membrane FGFR1 fusions,R-HSA-8853336
Signaling by activated point mutants of FGFR1,R-HSA-1839122
Signaling by cytosolic FGFR1 fusion mutants,R-HSA-1839117
Signaling by FGFR2 in disease,R-HSA-5655253
FGFR2 mutant receptor activation,R-HSA-1839126
Signaling by FGFR2 IIIa TM,R-HSA-8851708
Activated point mutants of FGFR2,R-HSA-2033519
Signaling by FGFR2 fusions,R-HSA-8853333
Signaling by FGFR2 amplification mutants,R-HSA-2023837
Signaling by FGFR3 in disease,R-HSA-5655332
Signaling by FGFR3 point mutants in cancer,R-HSA-8853338
FGFR3 mutant receptor activation,R-HSA-2033514
t(4;14) translocations of FGFR3,R-HSA-2033515
Signaling by activated point mutants of FGFR3,R-HSA-1839130
Signaling by FGFR3 fusions in cancer,R-HSA-8853334
Signaling by FGFR4 in disease,R-HSA-5655291
FGFR4 mutant receptor activation,R-HSA-1839128
Signaling by NOTCH1 in Cancer,R-HSA-2644603
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,R-HSA-2894858
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,R-HSA-2894862
Signaling by NOTCH1 PEST Domain Mutants in Cancer,R-HSA-2644602
Constitutive Signaling by NOTCH1 PEST Domain Mutants,R-HSA-2644606
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,R-HSA-2660825
Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,R-HSA-2660826
Signaling by NOTCH1 HD Domain Mutants in Cancer,R-HSA-2691230
Constitutive Signaling by NOTCH1 HD Domain Mutants,R-HSA-2691232
FBXW7 Mutants and NOTCH1 in Cancer,R-HSA-2644605
Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling,R-HSA-2644607
Hh mutants abrogate ligand secretion,R-HSA-5387390
HHAT G278V abrogates palmitoylation of Hh-Np,R-HSA-5658034
Hh mutants that don't undergo autocatalytic processing are degraded by ERAD,R-HSA-5362768
Signaling by WNT in cancer,R-HSA-4791275
"XAV939 inhibits tankyrase, stabilizing AXIN",R-HSA-5545619
Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling,R-HSA-5339717
RNF mutants show enhanced WNT signaling and proliferation,R-HSA-5340588
truncated APC mutants destabilize the destruction complex,R-HSA-4839744
APC truncation mutants have impaired AXIN binding,R-HSA-5467337
APC truncation mutants are not K63 polyubiquitinated,R-HSA-5467333
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex,R-HSA-4839743
S37 mutants of beta-catenin aren't phosphorylated,R-HSA-5358749
S33 mutants of beta-catenin aren't phosphorylated,R-HSA-5358747
S45 mutants of beta-catenin aren't phosphorylated,R-HSA-5358751
T41 mutants of beta-catenin aren't phosphorylated,R-HSA-5358752
WNT ligand secretion is abrogated by the PORCN inhibitor LGK974,R-HSA-5340573
"AXIN mutants destabilize the destruction complex, activating WNT signaling",R-HSA-4839735
Deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling,R-HSA-5467345
AXIN missense mutants destabilize the destruction complex,R-HSA-5467340
Misspliced GSK3beta mutants stabilize beta-catenin,R-HSA-5339716
AMER1 mutants destabilize the destruction complex,R-HSA-4839748
Deletions in the AMER1 gene destabilize the destruction complex,R-HSA-5467343
Truncations of AMER1 destabilize the destruction complex,R-HSA-5467348
TCF7L2 mutants don't bind CTBP,R-HSA-5339700
PI3K/AKT Signaling in Cancer,R-HSA-2219528
Constitutive Signaling by AKT1 E17K in Cancer,R-HSA-5674400
PTEN Loss of Function in Cancer,R-HSA-5674404
Constitutive Signaling by Aberrant PI3K in Cancer,R-HSA-2219530
Signaling by TGF-beta Receptor Complex in Cancer,R-HSA-3304351
Loss of Function of SMAD4 in Cancer,R-HSA-3304347
SMAD4 MH2 Domain Mutants in Cancer,R-HSA-3311021
Loss of Function of SMAD2/3 in Cancer,R-HSA-3304349
SMAD2/3 MH2 Domain Mutants in Cancer,R-HSA-3315487
SMAD2/3 Phosphorylation Motif Mutants in Cancer,R-HSA-3304356
Loss of Function of TGFBR2 in Cancer,R-HSA-3642278
TGFBR2 MSI Frameshift Mutants in Cancer,R-HSA-3642279
TGFBR2 Kinase Domain Mutants in Cancer,R-HSA-3645790
Loss of Function of TGFBR1 in Cancer,R-HSA-3656534
TGFBR1 LBD Mutants in Cancer,R-HSA-3656535
TGFBR1 KD Mutants in Cancer,R-HSA-3656532
Diseases associated with visual transduction,R-HSA-2474795
Retinoid cycle disease events,R-HSA-2453864
"Biosynthesis of A2E, implicated in retinal degradation",R-HSA-2466712
Retinoid metabolism disease events,R-HSA-6809583
Signaling by EGFR in Cancer,R-HSA-1643713
Signaling by EGFRvIII in Cancer,R-HSA-5637812
Constitutive Signaling by EGFRvIII,R-HSA-5637810
Signaling by Ligand-Responsive EGFR Variants in Cancer,R-HSA-5637815
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,R-HSA-1236382
Signaling by Overexpressed Wild-Type EGFR in Cancer,R-HSA-5638302
Inhibition of Signaling by Overexpressed EGFR,R-HSA-5638303
Diseases of Immune System,R-HSA-5260271
Diseases associated with the TLR signaling cascade,R-HSA-5602358
TICAM1 deficiency - HSE,R-HSA-5602566
TLR3 deficiency - HSE,R-HSA-5602410
IRAK4 deficiency (TLR5),R-HSA-5603037
MyD88 deficiency (TLR2/4),R-HSA-5602498
IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR),R-HSA-5603027
IkBA variant leads to EDA-ID,R-HSA-5603029
TRAF3 deficiency - HSE,R-HSA-5602571
MyD88 deficiency (TLR5),R-HSA-5602680
UNC93B1 deficiency - HSE,R-HSA-5602415
IKBKB deficiency causes SCID,R-HSA-5602636
IRAK4 deficiency (TLR2/4),R-HSA-5603041
Infectious disease,R-HSA-5663205
Latent infection of,R-HSA-1222352
Response of Mtb to phagocytosis,R-HSA-1222499
Mtb iron assimilation by chelation,R-HSA-1222449
Cell redox homeostasis,R-HSA-1222541
Tolerance by Mtb to nitric oxide produced by macrophages,R-HSA-1222538
Tolerance of reactive oxygen produced by macrophages,R-HSA-1222387
Influenza Infection,R-HSA-168254
Influenza Life Cycle,R-HSA-168255
Fusion and Uncoating of the Influenza Virion,R-HSA-168270
Fusion of the Influenza Virion to the Host Cell Endosome,R-HSA-168288
Uncoating of the Influenza Virion,R-HSA-168336
Transport of Ribonucleoproteins into the Host Nucleus,R-HSA-168271
Influenza Viral RNA Transcription and Replication,R-HSA-168273
vRNP Assembly,R-HSA-192905
Viral Messenger RNA Synthesis,R-HSA-168325
Viral mRNA Translation,R-HSA-192823
cRNA Synthesis,R-HSA-192869
vRNA Synthesis,R-HSA-192814
Virus Assembly and Release,R-HSA-168268
Release,R-HSA-168298
Packaging of Eight RNA Segments,R-HSA-168303
Assembly of Viral Components at the Budding Site,R-HSA-168316
"Transport of HA trimer, NA tetramer and M2 tetramer from the endoplasmic reticulum to the Golgi Apparatus",R-HSA-168874
Budding,R-HSA-168302
Export of Viral Ribonucleoproteins from Nucleus,R-HSA-168274
NEP/NS2 Interacts with the Cellular Export Machinery,R-HSA-168333
Viral RNP Complexes in the Host Cell Nucleus,R-HSA-168330
Entry of Influenza Virion into Host Cell via Endocytosis,R-HSA-168275
Host Interactions with Influenza Factors,R-HSA-168253
NS1 Mediated Effects on Host Pathways,R-HSA-168276
Inhibition of PKR,R-HSA-169131
Inhibition of Interferon Synthesis,R-HSA-168305
Inhibition of IFN-beta,R-HSA-168888
Inhibition of Host mRNA Processing and RNA Silencing,R-HSA-168315
Influenza Virus Induced Apoptosis,R-HSA-168277
HIV Infection,R-HSA-162906
Host Interactions of HIV factors,R-HSA-162909
Interactions of Rev with host cellular proteins,R-HSA-177243
Rev-mediated nuclear export of HIV RNA,R-HSA-165054
Nuclear import of Rev protein,R-HSA-180746
Interactions of Vpr with host cellular proteins,R-HSA-176033
Vpr-mediated nuclear import of PICs,R-HSA-180910
Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,R-HSA-180897
Interactions of Tat with host cellular proteins,R-HSA-176034
The role of Nef in HIV-1 replication and disease pathogenesis,R-HSA-164952
Nef and signal transduction,R-HSA-164944
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,R-HSA-164938
Nef mediated downregulation of MHC class I complex cell surface expression,R-HSA-164940
Nef Mediated CD8 Down-regulation,R-HSA-182218
Nef mediated downregulation of CD28 cell surface expression,R-HSA-164939
Nef Mediated CD4 Down-regulation,R-HSA-167590
Vif-mediated degradation of APOBEC3G,R-HSA-180585
APOBEC3G mediated resistance to HIV-1 infection,R-HSA-180689
Vpu mediated degradation of CD4,R-HSA-180534
HIV Life Cycle,R-HSA-162587
Early Phase of HIV Life Cycle,R-HSA-162594
Integration of provirus,R-HSA-162592
Autointegration results in viral DNA circles,R-HSA-177539
2-LTR circle formation,R-HSA-164843
Integration of viral DNA into host genomic DNA,R-HSA-175567
Binding and entry of HIV virion,R-HSA-173107
Reverse Transcription of HIV RNA,R-HSA-162589
Plus-strand DNA synthesis,R-HSA-164525
Minus-strand DNA synthesis,R-HSA-164516
Uncoating of the HIV Virion,R-HSA-162585
Late Phase of HIV Life Cycle,R-HSA-162599
Transcription of the HIV genome,R-HSA-167172
RNA Pol II CTD phosphorylation and interaction with CE,R-HSA-167160
Pausing and recovery of Tat-mediated HIV elongation,R-HSA-167238
HIV elongation arrest and recovery,R-HSA-167287
Formation of HIV elongation complex in the absence of HIV Tat,R-HSA-167152
HIV Transcription Initiation,R-HSA-167161
HIV Transcription Termination,R-HSA-167168
RNA Polymerase II HIV Promoter Escape,R-HSA-167162
Pausing and recovery of HIV elongation,R-HSA-167290
Tat-mediated HIV elongation arrest and recovery,R-HSA-167243
HIV Transcription Elongation,R-HSA-167169
Tat-mediated elongation of the HIV-1 transcript,R-HSA-167246
Formation of HIV-1 elongation complex containing HIV-1 Tat,R-HSA-167200
Abortive elongation of HIV-1 transcript in the absence of Tat,R-HSA-167242
Formation of the HIV-1 Early Elongation Complex,R-HSA-167158
Assembly Of The HIV Virion,R-HSA-175474
"Synthesis And Processing Of GAG, GAGPOL Polyproteins",R-HSA-174495
Membrane binding and targetting of GAG proteins,R-HSA-174490
Synthesis and processing of ENV and VPU,R-HSA-171286
Budding and maturation of HIV virion,R-HSA-162588
Rev-mediated nuclear export of HIV RNA,R-HSA-165054
Uptake and actions of bacterial toxins,R-HSA-5339562
Uptake and function of anthrax toxins,R-HSA-5210891
Uptake and function of diphtheria toxin,R-HSA-5336415
Neurotoxicity of clostridium toxins,R-HSA-168799
Toxicity of botulinum toxin type G (BoNT/G),R-HSA-5250989
Toxicity of botulinum toxin type A (BoNT/A),R-HSA-5250968
Toxicity of botulinum toxin type B (BoNT/B),R-HSA-5250958
Toxicity of tetanus toxin (TeNT),R-HSA-5250982
Toxicity of botulinum toxin type D (BoNT/D),R-HSA-5250955
Toxicity of botulinum toxin type C (BoNT/C),R-HSA-5250971
Toxicity of botulinum toxin type F (BoNT/F),R-HSA-5250981
Toxicity of botulinum toxin type E (BoNT/E),R-HSA-5250992
Cell-Cell communication,R-HSA-1500931
Signal regulatory protein (SIRP) family interactions,R-HSA-391160
Nephrin interactions,R-HSA-373753
DSCAM interactions,R-HSA-376172
Cell junction organization,R-HSA-446728
Cell-cell junction organization,R-HSA-421270
Adherens junctions interactions,R-HSA-418990
Nectin/Necl  trans heterodimerization,R-HSA-420597
Tight junction interactions,R-HSA-420029
Type I hemidesmosome assembly,R-HSA-446107
Cell-extracellular matrix interactions,R-HSA-446353
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,R-HSA-446388
Localization of the PINCH-ILK-PARVIN complex to focal adhesions,R-HSA-446343
Cell Cycle,R-HSA-1640170
"Cell Cycle, Mitotic",R-HSA-69278
M/G1 Transition,R-HSA-68874
DNA Replication Pre-Initiation,R-HSA-69002
Assembly of the pre-replicative complex,R-HSA-68867
CDT1 association with the CDC6:ORC:origin complex,R-HSA-68827
CDC6 association with the ORC:origin complex,R-HSA-68689
Assembly of the ORC complex at the origin of replication,R-HSA-68616
Activation of the pre-replicative complex,R-HSA-68962
Regulation of mitotic cell cycle,R-HSA-453276
APC/C-mediated degradation of cell cycle proteins,R-HSA-174143
Autodegradation of Cdh1 by Cdh1:APC/C,R-HSA-174084
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,R-HSA-176814
APC/C:Cdc20 mediated degradation of mitotic proteins,R-HSA-176409
APC/C:Cdc20 mediated degradation of Cyclin B,R-HSA-174048
APC/C:Cdc20 mediated degradation of Securin,R-HSA-174154
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,R-HSA-179419
APC-Cdc20 mediated degradation of Nek2A,R-HSA-179409
Cdc20:Phospho-APC/C mediated degradation of Cyclin A,R-HSA-174184
Phosphorylation of the APC/C,R-HSA-176412
Regulation of APC/C activators between G1/S and early anaphase,R-HSA-176408
SCF-beta-TrCP mediated degradation of Emi1,R-HSA-174113
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,R-HSA-141405
Inactivation of APC/C via direct inhibition of the APC/C complex,R-HSA-141430
Phosphorylation of Emi1,R-HSA-176417
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,R-HSA-174178
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,R-HSA-176407
Mitotic G1-G1/S phases,R-HSA-453279
G1 Phase,R-HSA-69236
Cyclin D associated events in G1,R-HSA-69231
G1/S Transition,R-HSA-69206
G1/S-Specific Transcription,R-HSA-69205
E2F mediated regulation of DNA replication,R-HSA-113510
E2F-enabled inhibition of pre-replication complex formation,R-HSA-113507
Inhibition of replication initiation of damaged DNA by RB1/E2F1,R-HSA-113501
Activation of the pre-replicative complex,R-HSA-68962
Cyclin E associated events during G1/S transition,R-HSA-69202
SCF(Skp2)-mediated degradation of p27/p21,R-HSA-187577
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes,R-HSA-69200
G0 and Early G1,R-HSA-1538133
S Phase,R-HSA-69242
Ubiquitin-dependent degradation of Cyclin D,R-HSA-75815
Ubiquitin-dependent degradation of Cyclin D1,R-HSA-69229
Synthesis of DNA,R-HSA-69239
DNA replication initiation,R-HSA-68952
Switching of origins to a post-replicative state,R-HSA-69052
Orc1 removal from chromatin,R-HSA-68949
CDK-mediated phosphorylation and removal of Cdc6,R-HSA-69017
DNA strand elongation,R-HSA-69190
Unwinding of DNA,R-HSA-176974
Leading Strand Synthesis,R-HSA-69109
Polymerase switching,R-HSA-69091
Lagging Strand Synthesis,R-HSA-69186
Processive synthesis on the lagging strand,R-HSA-69183
Removal of the Flap Intermediate,R-HSA-69166
Polymerase switching,R-HSA-69091
Establishment of Sister Chromatid Cohesion,R-HSA-2468052
Cyclin A:Cdk2-associated events at S phase entry,R-HSA-69656
SCF(Skp2)-mediated degradation of p27/p21,R-HSA-187577
Regulation of DNA replication,R-HSA-69304
Association of licensing factors with the pre-replicative complex,R-HSA-69298
Removal of licensing factors from origins,R-HSA-69300
CDK-mediated phosphorylation and removal of Cdc6,R-HSA-69017
Orc1 removal from chromatin,R-HSA-68949
M Phase,R-HSA-68886
Mitotic Telophase/Cytokinesis,R-HSA-68884
Cohesin Loading onto Chromatin,R-HSA-2470946
Mitotic Metaphase and Anaphase,R-HSA-2555396
Mitotic Anaphase,R-HSA-68882
Separation of Sister Chromatids,R-HSA-2467813
Nuclear Envelope Reassembly,R-HSA-2995410
Initiation of Nuclear Envelope Reformation,R-HSA-2995383
Mitotic Metaphase/Anaphase Transition,R-HSA-68881
Mitotic Prophase,R-HSA-68875
Nuclear Envelope Breakdown,R-HSA-2980766
Nuclear Pore Complex (NPC) Disassembly,R-HSA-3301854
Depolymerisation of the Nuclear Lamina,R-HSA-4419969
Clearance of Nuclear Envelope Membranes from Chromatin,R-HSA-2993913
"Activation of NIMA Kinases NEK9, NEK6, NEK7",R-HSA-2980767
MASTL Facilitates Mitotic Progression,R-HSA-2465910
Golgi Cisternae Pericentriolar Stack Reorganization,R-HSA-162658
Condensation of Prophase Chromosomes,R-HSA-2299718
Mitotic Prometaphase,R-HSA-68877
Condensation of Prometaphase Chromosomes,R-HSA-2514853
Resolution of Sister Chromatid Cohesion,R-HSA-2500257
Mitotic G2-G2/M phases,R-HSA-453274
G2 Phase,R-HSA-68911
G2/M Transition,R-HSA-69275
Interaction between PHLDA1 and AURKA,R-HSA-8854521
Polo-like kinase mediated events,R-HSA-156711
AURKA Activation by TPX2,R-HSA-8854518
Cyclin B2 mediated events,R-HSA-157881
Regulation of PLK1 Activity at G2/M Transition,R-HSA-2565942
Cyclin A/B1 associated events during G2/M transition,R-HSA-69273
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes,R-HSA-170145
Centrosome maturation,R-HSA-380287
Loss of proteins required for interphase microtubule organization from the centrosome,R-HSA-380284
Loss of Nlp from mitotic centrosomes,R-HSA-380259
Recruitment of mitotic centrosome proteins and complexes,R-HSA-380270
Recruitment of NuMA to mitotic centrosomes,R-HSA-380320
The role of GTSE1 in G2/M progression after G2 checkpoint,R-HSA-8852276
Meiosis,R-HSA-1500620
Meiotic recombination,R-HSA-912446
Meiotic synapsis,R-HSA-1221632
Chromosome Maintenance,R-HSA-73886
Nucleosome assembly,R-HSA-774815
Deposition of new CENPA-containing nucleosomes at the centromere,R-HSA-606279
Telomere Maintenance,R-HSA-157579
Extension of Telomeres,R-HSA-180786
Telomere Extension By Telomerase,R-HSA-171319
Telomere C-strand (Lagging Strand) Synthesis,R-HSA-174417
Polymerase switching on the C-strand of the telomere,R-HSA-174411
Telomere C-strand synthesis initiation,R-HSA-174430
Processive synthesis on the C-strand of the telomere,R-HSA-174414
Removal of the Flap Intermediate from the C-strand,R-HSA-174437
Packaging Of Telomere Ends,R-HSA-171306
Cell Cycle Checkpoints,R-HSA-69620
G1/S DNA Damage Checkpoints,R-HSA-69615
p53-Dependent G1/S DNA damage checkpoint,R-HSA-69580
p53-Dependent G1 DNA Damage Response,R-HSA-69563
Stabilization of p53,R-HSA-69541
Autodegradation of the E3 ubiquitin ligase COP1,R-HSA-349425
Transcriptional activation of p53 responsive genes,R-HSA-69560
Transcriptional  activation of  cell cycle inhibitor p21,R-HSA-69895
p53-Independent G1/S DNA damage checkpoint,R-HSA-69613
p53-Independent DNA Damage Response,R-HSA-69610
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,R-HSA-69601
Mitotic Spindle Checkpoint,R-HSA-69618
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,R-HSA-141405
Inactivation of APC/C via direct inhibition of the APC/C complex,R-HSA-141430
Amplification of signal from the kinetochores,R-HSA-141424
Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,R-HSA-141444
G2/M Checkpoints,R-HSA-69481
Activation of ATR in response to replication stress,R-HSA-176187
G2/M DNA replication checkpoint,R-HSA-69478
G2/M DNA damage checkpoint,R-HSA-69473
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,R-HSA-75035
DNA Repair,R-HSA-73894
Mismatch Repair,R-HSA-5358508
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),R-HSA-5358606
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),R-HSA-5358565
Base Excision Repair,R-HSA-73884
Resolution of Abasic Sites (AP sites),R-HSA-73933
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway,R-HSA-5649702
Resolution of AP sites via the multiple-nucleotide patch replacement pathway,R-HSA-110373
POLB-Dependent Long Patch Base Excision Repair,R-HSA-110362
PCNA-Dependent Long Patch Base Excision Repair,R-HSA-5651801
Resolution of AP sites via the single-nucleotide replacement pathway,R-HSA-110381
Abasic sugar-phosphate removal via the single-nucleotide replacement pathway,R-HSA-73930
Displacement of DNA glycosylase by APEX1,R-HSA-110357
"Base-Excision Repair, AP Site Formation",R-HSA-73929
Depyrimidination,R-HSA-73928
Cleavage of the damaged pyrimidine,R-HSA-110329
Recognition and association of DNA glycosylase with site containing an affected pyrimidine,R-HSA-110328
Depurination,R-HSA-73927
Cleavage of the damaged purine,R-HSA-110331
Recognition and association of DNA glycosylase with site containing an affected purine,R-HSA-110330
Nucleotide Excision Repair,R-HSA-5696398
Global Genome Nucleotide Excision Repair (GG-NER),R-HSA-5696399
Formation of Incision Complex in GG-NER,R-HSA-5696395
Dual Incision in GG-NER,R-HSA-5696400
Gap-filling DNA repair synthesis and ligation in GG-NER,R-HSA-5696397
DNA Damage Recognition in GG-NER,R-HSA-5696394
Transcription-Coupled Nucleotide Excision Repair (TC-NER),R-HSA-6781827
Dual incision in TC-NER,R-HSA-6782135
Formation of TC-NER Pre-Incision Complex,R-HSA-6781823
Gap-filling DNA repair synthesis and ligation in TC-NER,R-HSA-6782210
Fanconi Anemia Pathway,R-HSA-6783310
DNA Damage Reversal,R-HSA-73942
MGMT-mediated DNA damage reversal,R-HSA-5657655
Reversal of alkylation damage by DNA dioxygenases,R-HSA-73943
ALKBH3 mediated reversal of alkylation damage,R-HSA-112126
ALKBH2 mediated reversal of alkylation damage,R-HSA-112122
DNA Double-Strand Break Repair,R-HSA-5693532
Nonhomologous End-Joining (NHEJ),R-HSA-5693571
DNA Double Strand Break Response,R-HSA-5693606
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,R-HSA-5693565
Sensing of DNA Double Strand Breaks,R-HSA-5693548
,R-HSA-5693538
HDR through MMEJ (alt-NHEJ),R-HSA-5685939
HDR through,R-HSA-5693567
HDR through Single Strand Annealing (SSA),R-HSA-5685938
HDR through,R-HSA-5685942
,R-HSA-5693579
Presynaptic phase of homologous DNA pairing and strand exchange,R-HSA-5693616
Resolution of D-Loop Structures,R-HSA-5693537
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA),R-HSA-5693554
Resolution of D-loop Structures through Holliday Junction Intermediates,R-HSA-5693568
Processing of DNA double-strand break ends,R-HSA-5693607
DNA Damage Bypass,R-HSA-73893
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,R-HSA-110313
Termination of translesion DNA synthesis,R-HSA-5656169
Translesion Synthesis by POLH,R-HSA-110320
Translesion synthesis by REV1,R-HSA-110312
Translesion synthesis by POLK,R-HSA-5655862
Translesion synthesis by POLI,R-HSA-5656121
Recognition of DNA damage by PCNA-containing replication complex,R-HSA-110314
Immune System,R-HSA-168256
Adaptive Immune System,R-HSA-1280218
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,R-HSA-198933
Costimulation by the CD28 family,R-HSA-388841
CTLA4 inhibitory signaling,R-HSA-389513
PD-1 signaling,R-HSA-389948
CD28 co-stimulation,R-HSA-389356
CD28 dependent PI3K/Akt signaling,R-HSA-389357
CD28 dependent Vav1 pathway,R-HSA-389359
MHC class II antigen presentation,R-HSA-2132295
TCR signaling,R-HSA-202403
Translocation of ZAP-70 to Immunological synapse,R-HSA-202430
Downstream TCR signaling,R-HSA-202424
Phosphorylation of CD3 and TCR zeta chains,R-HSA-202427
Generation of second messenger molecules,R-HSA-202433
Rap1 signalling,R-HSA-392517
Signaling by the B Cell Receptor (BCR),R-HSA-983705
Downstream signaling events of B Cell Receptor (BCR),R-HSA-1168372
Activation of RAS in B cells,R-HSA-1169092
Activation of NF-kappaB in B cells,R-HSA-1169091
PIP3 activates AKT signaling,R-HSA-1257604
AKT phosphorylates targets in the cytosol,R-HSA-198323
Negative regulation of the PI3K/AKT network,R-HSA-199418
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",R-HSA-6811558
AKT phosphorylates targets in the nucleus,R-HSA-198693
CD22 mediated BCR regulation,R-HSA-5690714
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,R-HSA-983695
Class I MHC mediated antigen processing & presentation,R-HSA-983169
Antigen processing-Cross presentation,R-HSA-1236975
ER-Phagosome pathway,R-HSA-1236974
Cross-presentation of soluble exogenous antigens (endosomes),R-HSA-1236978
Cross-presentation of particulate exogenous antigens (phagosomes),R-HSA-1236973
Endosomal/Vacuolar pathway,R-HSA-1236977
Antigen processing: Ubiquitination & Proteasome degradation,R-HSA-983168
"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",R-HSA-983170
Innate Immune System,R-HSA-168249
Fc epsilon receptor (FCERI) signaling,R-HSA-2454202
Role of LAT2/NTAL/LAB on calcium mobilization,R-HSA-2730905
PIP3 activates AKT signaling,R-HSA-1257604
AKT phosphorylates targets in the cytosol,R-HSA-198323
Negative regulation of the PI3K/AKT network,R-HSA-199418
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",R-HSA-6811558
AKT phosphorylates targets in the nucleus,R-HSA-198693
FCERI mediated NF-kB activation,R-HSA-2871837
FCERI mediated MAPK activation,R-HSA-2871796
RAF/MAP kinase cascade,R-HSA-5673001
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
RAF activation,R-HSA-5673000
MAP2K and MAPK activation,R-HSA-5674135
Regulation of RAS by GAPs,R-HSA-5658442
FCERI mediated Ca+2 mobilization,R-HSA-2871809
Defensins,R-HSA-1461973
Alpha-defensins,R-HSA-1462054
Beta defensins,R-HSA-1461957
Toll-Like Receptors Cascades,R-HSA-168898
Toll Like Receptor 3 (TLR3) Cascade,R-HSA-168164
MyD88-independent TLR3/TLR4 cascade,R-HSA-166166
TRIF-mediated TLR3/TLR4 signaling,R-HSA-937061
MAP kinase activation in TLR cascade,R-HSA-450294
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,R-HSA-450321
MAP3K8 (TPL2)-dependent MAPK1/3 activation,R-HSA-5684264
activated TAK1 mediates p38 MAPK activation,R-HSA-450302
MAPK targets/ Nuclear events mediated by MAP kinases,R-HSA-450282
ERK/MAPK targets,R-HSA-198753
ERKs are inactivated,R-HSA-202670
Activation of the AP-1 family of transcription factors,R-HSA-450341
CREB phosphorylation,R-HSA-199920
TRIF-mediated programmed cell death,R-HSA-2562578
IKK complex recruitment mediated by RIP1,R-HSA-937041
TRAF6 mediated induction of TAK1 complex,R-HSA-937072
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,R-HSA-936964
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,R-HSA-445989
Toll Like Receptor 9 (TLR9) Cascade,R-HSA-168138
MyD88 dependent cascade initiated on endosome,R-HSA-975155
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,R-HSA-975110
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,R-HSA-975138
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,R-HSA-975163
MAP kinase activation in TLR cascade,R-HSA-450294
MAP3K8 (TPL2)-dependent MAPK1/3 activation,R-HSA-5684264
activated TAK1 mediates p38 MAPK activation,R-HSA-450302
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,R-HSA-450321
MAPK targets/ Nuclear events mediated by MAP kinases,R-HSA-450282
ERK/MAPK targets,R-HSA-198753
ERKs are inactivated,R-HSA-202670
Activation of the AP-1 family of transcription factors,R-HSA-450341
CREB phosphorylation,R-HSA-199920
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,R-HSA-975144
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,R-HSA-445989
Toll Like Receptor 5 (TLR5) Cascade,R-HSA-168176
MyD88 cascade initiated on plasma membrane,R-HSA-975871
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,R-HSA-445989
MAP kinase activation in TLR cascade,R-HSA-450294
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,R-HSA-450321
MAP3K8 (TPL2)-dependent MAPK1/3 activation,R-HSA-5684264
activated TAK1 mediates p38 MAPK activation,R-HSA-450302
MAPK targets/ Nuclear events mediated by MAP kinases,R-HSA-450282
CREB phosphorylation,R-HSA-199920
Activation of the AP-1 family of transcription factors,R-HSA-450341
ERK/MAPK targets,R-HSA-198753
ERKs are inactivated,R-HSA-202670
IRAK2 mediated activation of TAK1 complex,R-HSA-937042
IRAK1 recruits IKK complex,R-HSA-937039
Toll Like Receptor 7/8 (TLR7/8) Cascade,R-HSA-168181
MyD88 dependent cascade initiated on endosome,R-HSA-975155
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,R-HSA-975138
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,R-HSA-975163
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,R-HSA-975144
MAP kinase activation in TLR cascade,R-HSA-450294
MAPK targets/ Nuclear events mediated by MAP kinases,R-HSA-450282
Activation of the AP-1 family of transcription factors,R-HSA-450341
ERK/MAPK targets,R-HSA-198753
ERKs are inactivated,R-HSA-202670
CREB phosphorylation,R-HSA-199920
MAP3K8 (TPL2)-dependent MAPK1/3 activation,R-HSA-5684264
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,R-HSA-450321
activated TAK1 mediates p38 MAPK activation,R-HSA-450302
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,R-HSA-445989
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,R-HSA-975110
Toll Like Receptor 2 (TLR2) Cascade,R-HSA-181438
Toll Like Receptor TLR6:TLR2 Cascade,R-HSA-168188
MyD88:Mal cascade initiated on plasma membrane,R-HSA-166058
IRAK1 recruits IKK complex,R-HSA-937039
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,R-HSA-445989
MAP kinase activation in TLR cascade,R-HSA-450294
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,R-HSA-450321
MAPK targets/ Nuclear events mediated by MAP kinases,R-HSA-450282
Activation of the AP-1 family of transcription factors,R-HSA-450341
ERK/MAPK targets,R-HSA-198753
ERKs are inactivated,R-HSA-202670
CREB phosphorylation,R-HSA-199920
MAP3K8 (TPL2)-dependent MAPK1/3 activation,R-HSA-5684264
activated TAK1 mediates p38 MAPK activation,R-HSA-450302
IRAK2 mediated activation of TAK1 complex,R-HSA-937042
Toll Like Receptor TLR1:TLR2 Cascade,R-HSA-168179
MyD88:Mal cascade initiated on plasma membrane,R-HSA-166058
IRAK1 recruits IKK complex,R-HSA-937039
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,R-HSA-445989
MAP kinase activation in TLR cascade,R-HSA-450294
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,R-HSA-450321
activated TAK1 mediates p38 MAPK activation,R-HSA-450302
MAP3K8 (TPL2)-dependent MAPK1/3 activation,R-HSA-5684264
MAPK targets/ Nuclear events mediated by MAP kinases,R-HSA-450282
CREB phosphorylation,R-HSA-199920
Activation of the AP-1 family of transcription factors,R-HSA-450341
ERK/MAPK targets,R-HSA-198753
ERKs are inactivated,R-HSA-202670
IRAK2 mediated activation of TAK1 complex,R-HSA-937042
Toll Like Receptor 10 (TLR10) Cascade,R-HSA-168142
MyD88 cascade initiated on plasma membrane,R-HSA-975871
IRAK2 mediated activation of TAK1 complex,R-HSA-937042
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,R-HSA-445989
MAP kinase activation in TLR cascade,R-HSA-450294
MAPK targets/ Nuclear events mediated by MAP kinases,R-HSA-450282
CREB phosphorylation,R-HSA-199920
ERK/MAPK targets,R-HSA-198753
ERKs are inactivated,R-HSA-202670
Activation of the AP-1 family of transcription factors,R-HSA-450341
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,R-HSA-450321
MAP3K8 (TPL2)-dependent MAPK1/3 activation,R-HSA-5684264
activated TAK1 mediates p38 MAPK activation,R-HSA-450302
IRAK1 recruits IKK complex,R-HSA-937039
Regulation of TLR by endogenous ligand,R-HSA-5686938
Toll Like Receptor 4 (TLR4) Cascade,R-HSA-166016
Transfer of LPS from LBP carrier to CD14,R-HSA-166020
Activated TLR4 signalling,R-HSA-166054
MyD88-independent TLR3/TLR4 cascade,R-HSA-166166
TRIF-mediated TLR3/TLR4 signaling,R-HSA-937061
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,R-HSA-445989
MAP kinase activation in TLR cascade,R-HSA-450294
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,R-HSA-450321
activated TAK1 mediates p38 MAPK activation,R-HSA-450302
MAPK targets/ Nuclear events mediated by MAP kinases,R-HSA-450282
Activation of the AP-1 family of transcription factors,R-HSA-450341
ERK/MAPK targets,R-HSA-198753
ERKs are inactivated,R-HSA-202670
CREB phosphorylation,R-HSA-199920
MAP3K8 (TPL2)-dependent MAPK1/3 activation,R-HSA-5684264
TRAF6 mediated induction of TAK1 complex,R-HSA-937072
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,R-HSA-936964
TRIF-mediated programmed cell death,R-HSA-2562578
IKK complex recruitment mediated by RIP1,R-HSA-937041
MyD88:Mal cascade initiated on plasma membrane,R-HSA-166058
IRAK1 recruits IKK complex,R-HSA-937039
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,R-HSA-445989
MAP kinase activation in TLR cascade,R-HSA-450294
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,R-HSA-450321
MAPK targets/ Nuclear events mediated by MAP kinases,R-HSA-450282
ERK/MAPK targets,R-HSA-198753
ERKs are inactivated,R-HSA-202670
CREB phosphorylation,R-HSA-199920
Activation of the AP-1 family of transcription factors,R-HSA-450341
MAP3K8 (TPL2)-dependent MAPK1/3 activation,R-HSA-5684264
activated TAK1 mediates p38 MAPK activation,R-HSA-450302
IRAK2 mediated activation of TAK1 complex,R-HSA-937042
Trafficking and processing of endosomal TLR,R-HSA-1679131
Fcgamma receptor (FCGR) dependent phagocytosis,R-HSA-2029480
FCGR activation,R-HSA-2029481
Regulation of actin dynamics for phagocytic cup formation,R-HSA-2029482
Role of phospholipids in phagocytosis,R-HSA-2029485
Cytosolic sensors of pathogen-associated DNA,R-HSA-1834949
STING mediated induction of host immune responses,R-HSA-1834941
IRF3-mediated induction of type I IFN,R-HSA-3270619
STAT6-mediated induction of chemokines,R-HSA-3249367
ZBP1(DAI) mediated induction of type I IFNs,R-HSA-1606322
RIP-mediated NFkB activation via ZBP1,R-HSA-1810476
IRF3 mediated activation of type 1 IFN,R-HSA-1606341
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,R-HSA-3134973
DEx/H-box helicases activate type I IFN and inflammatory cytokines production,R-HSA-3134963
Regulation of innate immune responses to cytosolic DNA,R-HSA-3134975
Regulation by TREX1,R-HSA-3248023
Complement cascade,R-HSA-166658
Terminal pathway of complement,R-HSA-166665
Initial triggering of complement,R-HSA-166663
Creation of C4 and C2 activators,R-HSA-166786
Classical antibody-mediated complement activation,R-HSA-173623
Lectin pathway of complement activation,R-HSA-166662
Ficolins bind to repetitive carbohydrate structures on the target cell surface,R-HSA-2855086
Alternative complement activation,R-HSA-173736
Activation of C3 and C5,R-HSA-174577
Regulation of Complement cascade,R-HSA-977606
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways,R-HSA-168928
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,R-HSA-933543
TRAF6 mediated IRF7 activation,R-HSA-933541
TRAF3-dependent IRF activation pathway,R-HSA-918233
Negative regulators of RIG-I/MDA5 signaling,R-HSA-936440
TRAF6 mediated NF-kB activation,R-HSA-933542
DAP12 interactions,R-HSA-2172127
DAP12 signaling,R-HSA-2424491
DAG and IP3 signaling,R-HSA-1489509
CaM pathway,R-HSA-111997
Calmodulin induced events,R-HSA-111933
CaMK IV-mediated phosphorylation of CREB,R-HSA-111932
Cam-PDE 1 activation,R-HSA-111957
PKA-mediated phosphorylation of CREB,R-HSA-111931
PKA activation,R-HSA-163615
PIP3 activates AKT signaling,R-HSA-1257604
Negative regulation of the PI3K/AKT network,R-HSA-199418
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",R-HSA-6811558
AKT phosphorylates targets in the cytosol,R-HSA-198323
AKT phosphorylates targets in the nucleus,R-HSA-198693
RAF/MAP kinase cascade,R-HSA-5673001
MAP2K and MAPK activation,R-HSA-5674135
Regulation of RAS by GAPs,R-HSA-5658442
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
RAF activation,R-HSA-5673000
"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",R-HSA-168643
Inflammasomes,R-HSA-622312
The IPAF inflammasome,R-HSA-844623
The NLRP1 inflammasome,R-HSA-844455
The NLRP3 inflammasome,R-HSA-844456
The AIM2 inflammasome,R-HSA-844615
NOD1/2 Signaling Pathway,R-HSA-168638
C-type lectin receptors (CLRs),R-HSA-5621481
CLEC7A (Dectin-1) signaling,R-HSA-5607764
Dectin-1 mediated noncanonical NF-kB signaling,R-HSA-5607761
CLEC7A (Dectin-1) induces NFAT activation,R-HSA-5607763
CLEC7A/inflammasome pathway,R-HSA-5660668
CD209 (DC-SIGN) signaling,R-HSA-5621575
Dectin-2 family,R-HSA-5621480
Advanced glycosylation endproduct receptor signaling,R-HSA-879415
Cytokine Signaling in Immune system,R-HSA-1280215
Signaling by Interleukins,R-HSA-449147
"Interleukin-3, 5 and GM-CSF signaling",R-HSA-512988
Regulation of signaling by CBL,R-HSA-912631
Interleukin receptor SHC signaling,R-HSA-912526
RAF/MAP kinase cascade,R-HSA-5673001
Regulation of RAS by GAPs,R-HSA-5658442
RAF activation,R-HSA-5673000
MAP2K and MAPK activation,R-HSA-5674135
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
Interleukin-12 signaling,R-HSA-447115
Interleukin-7 signaling,R-HSA-1266695
Interleukin-1 processing,R-HSA-448706
Interleukin-1 signaling,R-HSA-446652
MAP3K8 (TPL2)-dependent MAPK1/3 activation,R-HSA-5684264
Interleukin-6 family signaling,R-HSA-6783589
IL-6-type cytokine receptor ligand interactions,R-HSA-6788467
Interleukin-6 signaling,R-HSA-1059683
Interleukin-17 signaling,R-HSA-448424
Interleukin-2 signaling,R-HSA-451927
Interleukin receptor SHC signaling,R-HSA-912526
RAF/MAP kinase cascade,R-HSA-5673001
RAF activation,R-HSA-5673000
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
Regulation of RAS by GAPs,R-HSA-5658442
MAP2K and MAPK activation,R-HSA-5674135
RAF/MAP kinase cascade,R-HSA-5673001
MAP2K and MAPK activation,R-HSA-5674135
RAF activation,R-HSA-5673000
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
Regulation of RAS by GAPs,R-HSA-5658442
"Interleukin-19, 20, 22, 24",R-HSA-8854691
Interferon Signaling,R-HSA-913531
Interferon gamma signaling,R-HSA-877300
Regulation of IFNG signaling,R-HSA-877312
Antiviral mechanism by IFN-stimulated genes,R-HSA-1169410
ISG15 antiviral mechanism,R-HSA-1169408
Interferon alpha/beta signaling,R-HSA-909733
Regulation of IFNA signaling,R-HSA-912694
TNFR2 non-canonical NF-kB pathway,R-HSA-5668541
TNFs bind their physiological receptors,R-HSA-5669034
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,R-HSA-5676594
NIK-->noncanonical NF-kB signaling,R-HSA-5676590
Growth hormone receptor signaling,R-HSA-982772
Prolactin receptor signaling,R-HSA-1170546
"ROS, RNS production in response to bacteria",R-HSA-1222556
Reproduction,R-HSA-1474165
Fertilization,R-HSA-1187000
Acrosome Reaction,R-HSA-1300645
Sperm:Oocyte Membrane Binding,R-HSA-1300652
Interaction With The Zona Pellucida,R-HSA-1300644
Sperm Motility And Taxes,R-HSA-1300642
Interaction With Cumulus Cells,R-HSA-2534343
Signal Transduction,R-HSA-162582
Signaling by PTK6,R-HSA-8848021
ERBB2 Activates PTK6 Signaling,R-HSA-8847993
PTK6 Expression,R-HSA-8849473
PTK6 Regulates Cell Cycle,R-HSA-8849470
PTK6 Regulates Proteins Involved in RNA Processing,R-HSA-8849468
PTK6 Down-Regulation,R-HSA-8849472
"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases",R-HSA-8849471
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1,R-HSA-8849469
PTK6 promotes HIF1A stabilization,R-HSA-8857538
PTK6 Activates STAT3,R-HSA-8849474
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),R-HSA-2404192
IGF1R signaling cascade,R-HSA-2428924
IRS-related events triggered by IGF1R,R-HSA-2428928
IRS-mediated signalling,R-HSA-112399
SOS-mediated signalling,R-HSA-112412
RAF/MAP kinase cascade,R-HSA-5673001
RAF activation,R-HSA-5673000
MAP2K and MAPK activation,R-HSA-5674135
Regulation of RAS by GAPs,R-HSA-5658442
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
PI3K Cascade,R-HSA-109704
Activation of AKT2,R-HSA-165158
PKB-mediated events,R-HSA-109703
mTOR signalling,R-HSA-165159
mTORC1-mediated signalling,R-HSA-166208
Inhibition of TSC complex formation by PKB,R-HSA-165181
Energy dependent regulation of mTOR by LKB1-AMPK,R-HSA-380972
PDE3B signalling,R-HSA-165160
SHC-related events triggered by IGF1R,R-HSA-2428933
DAG and IP3 signaling,R-HSA-1489509
CaM pathway,R-HSA-111997
Calmodulin induced events,R-HSA-111933
PKA-mediated phosphorylation of CREB,R-HSA-111931
PKA activation,R-HSA-163615
Cam-PDE 1 activation,R-HSA-111957
CaMK IV-mediated phosphorylation of CREB,R-HSA-111932
Signaling by GPCR,R-HSA-372790
GPCR ligand binding,R-HSA-500792
Class C/3 (Metabotropic glutamate/pheromone receptors),R-HSA-420499
Class A/1 (Rhodopsin-like receptors),R-HSA-373076
Peptide ligand-binding receptors,R-HSA-375276
Vasopressin-like receptors,R-HSA-388479
Chemokine receptors bind chemokines,R-HSA-380108
Tachykinin receptors bind tachykinins,R-HSA-380095
Formyl peptide receptors bind formyl peptides and many other ligands,R-HSA-444473
Relaxin receptors,R-HSA-444821
Orexin and neuropeptides FF and QRFP bind to their respective receptors,R-HSA-389397
Lysosphingolipid and LPA receptors,R-HSA-419408
Hydroxycarboxylic acid-binding receptors,R-HSA-3296197
Hormone ligand-binding receptors,R-HSA-375281
Eicosanoid ligand-binding receptors,R-HSA-391903
Leukotriene receptors,R-HSA-391906
Prostanoid ligand receptors,R-HSA-391908
Amine ligand-binding receptors,R-HSA-375280
Dopamine receptors,R-HSA-390651
Serotonin receptors,R-HSA-390666
Muscarinic acetylcholine receptors,R-HSA-390648
Histamine receptors,R-HSA-390650
Adrenoceptors,R-HSA-390696
Nucleotide-like (purinergic) receptors,R-HSA-418038
Adenosine P1 receptors,R-HSA-417973
P2Y receptors,R-HSA-417957
Opsins,R-HSA-419771
Free fatty acid receptors,R-HSA-444209
Class B/2 (Secretin family receptors),R-HSA-373080
Calcitonin-like ligand receptors,R-HSA-419812
Glucagon-type ligand receptors,R-HSA-420092
GPCR downstream signaling,R-HSA-388396
G alpha (q) signalling events,R-HSA-416476
Effects of PIP2 hydrolysis,R-HSA-114508
Arachidonate production from DAG,R-HSA-426048
G alpha (i) signalling events,R-HSA-418594
G-protein beta:gamma signalling,R-HSA-397795
G beta:gamma signalling through PI3Kgamma,R-HSA-392451
G beta:gamma signalling through PLC beta,R-HSA-418217
G alpha (s) signalling events,R-HSA-418555
G alpha (12/13) signalling events,R-HSA-416482
Olfactory Signaling Pathway,R-HSA-381753
G alpha (z) signalling events,R-HSA-418597
Gastrin-CREB signalling pathway via PKC and MAPK,R-HSA-881907
EGFR Transactivation by Gastrin,R-HSA-2179392
G alpha (q) signalling events,R-HSA-416476
Effects of PIP2 hydrolysis,R-HSA-114508
Arachidonate production from DAG,R-HSA-426048
RAF/MAP kinase cascade,R-HSA-5673001
RAF activation,R-HSA-5673000
Regulation of RAS by GAPs,R-HSA-5658442
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
MAP2K and MAPK activation,R-HSA-5674135
Opioid Signalling,R-HSA-111885
G-protein mediated events,R-HSA-112040
Adenylate cyclase inhibitory pathway,R-HSA-170670
PLC beta mediated events,R-HSA-112043
Ca-dependent events,R-HSA-111996
phospho-PLA2 pathway,R-HSA-111995
CaM pathway,R-HSA-111997
Calmodulin induced events,R-HSA-111933
Cam-PDE 1 activation,R-HSA-111957
PKA-mediated phosphorylation of CREB,R-HSA-111931
PKA activation,R-HSA-163615
CaMK IV-mediated phosphorylation of CREB,R-HSA-111932
Adenylate cyclase activating pathway,R-HSA-170660
DARPP-32 events,R-HSA-180024
G-protein activation,R-HSA-202040
Signaling by Hedgehog,R-HSA-5358351
Hedgehog 'off' state,R-HSA-5610787
Degradation of GLI2 by the proteasome,R-HSA-5610783
GLI3 is processed to GLI3R by the proteasome,R-HSA-5610785
Degradation of GLI1 by the proteasome,R-HSA-5610780
Hedgehog ligand biogenesis,R-HSA-5358346
Release of Hh-Np from the secreting cell,R-HSA-5362798
Hedgehog 'on' state,R-HSA-5632684
Ligand-receptor interactions,R-HSA-5632681
GLI proteins bind promoters of Hh responsive genes to promote transcription,R-HSA-5635851
Activation of SMO,R-HSA-5635838
Signaling by Leptin,R-HSA-2586552
RAF/MAP kinase cascade,R-HSA-5673001
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
MAP2K and MAPK activation,R-HSA-5674135
RAF activation,R-HSA-5673000
Regulation of RAS by GAPs,R-HSA-5658442
Death Receptor Signalling,R-HSA-73887
FasL/ CD95L signaling,R-HSA-75157
TRAIL  signaling,R-HSA-75158
TNF signaling,R-HSA-75893
TNFR1-induced NFkappaB signaling pathway,R-HSA-5357956
TNFR1-induced proapoptotic signaling,R-HSA-5357786
Regulation of TNFR1 signaling,R-HSA-5357905
TNFR1-mediated ceramide production,R-HSA-5626978
Signaling by Retinoic Acid,R-HSA-5362517
RA biosynthesis pathway,R-HSA-5365859
Signaling by Rho GTPases,R-HSA-194315
RHO GTPase Effectors,R-HSA-195258
RHO GTPases Activate Rhotekin and Rhophilins,R-HSA-5666185
RHO GTPases Activate NADPH Oxidases,R-HSA-5668599
RHO GTPases Activate WASPs and WAVEs,R-HSA-5663213
RHO GTPases activate IQGAPs,R-HSA-5626467
RHO GTPases regulate CFTR trafficking,R-HSA-5627083
RHO GTPases activate CIT,R-HSA-5625900
RHO GTPases activate KTN1,R-HSA-5625970
RHO GTPases Activate ROCKs,R-HSA-5627117
RHO GTPases activate PAKs,R-HSA-5627123
RHO GTPases Activate Formins,R-HSA-5663220
RHO GTPases activate PKNs,R-HSA-5625740
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,R-HSA-5625886
Rho GTPase cycle,R-HSA-194840
Integrin alphaIIb beta3 signaling,R-HSA-354192
GRB2:SOS provides linkage to MAPK signaling for Integrins,R-HSA-354194
p130Cas linkage to MAPK signaling for integrins,R-HSA-372708
Signaling by TGF-beta Receptor Complex,R-HSA-170834
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),R-HSA-2173791
TGF-beta receptor signaling activates SMADs,R-HSA-2173789
Downregulation of TGF-beta receptor signaling,R-HSA-2173788
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,R-HSA-2173793
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,R-HSA-2173796
Downregulation of SMAD2/3:SMAD4 transcriptional activity,R-HSA-2173795
PIP3 activates AKT signaling,R-HSA-1257604
AKT phosphorylates targets in the nucleus,R-HSA-198693
Negative regulation of the PI3K/AKT network,R-HSA-199418
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",R-HSA-6811558
AKT phosphorylates targets in the cytosol,R-HSA-198323
Signaling by EGFR,R-HSA-177929
GAB1 signalosome,R-HSA-180292
PIP3 activates AKT signaling,R-HSA-1257604
Negative regulation of the PI3K/AKT network,R-HSA-199418
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",R-HSA-6811558
AKT phosphorylates targets in the nucleus,R-HSA-198693
AKT phosphorylates targets in the cytosol,R-HSA-198323
EGFR downregulation,R-HSA-182971
EGFR interacts with phospholipase C-gamma,R-HSA-212718
DAG and IP3 signaling,R-HSA-1489509
CaM pathway,R-HSA-111997
Calmodulin induced events,R-HSA-111933
CaMK IV-mediated phosphorylation of CREB,R-HSA-111932
PKA-mediated phosphorylation of CREB,R-HSA-111931
PKA activation,R-HSA-163615
Cam-PDE 1 activation,R-HSA-111957
GRB2 events in EGFR signaling,R-HSA-179812
RAF/MAP kinase cascade,R-HSA-5673001
Regulation of RAS by GAPs,R-HSA-5658442
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
RAF activation,R-HSA-5673000
MAP2K and MAPK activation,R-HSA-5674135
SHC1 events in EGFR signaling,R-HSA-180336
RAF/MAP kinase cascade,R-HSA-5673001
Regulation of RAS by GAPs,R-HSA-5658442
MAP2K and MAPK activation,R-HSA-5674135
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
RAF activation,R-HSA-5673000
Signaling by BMP,R-HSA-201451
Signalling by NGF,R-HSA-166520
p75 NTR receptor-mediated signalling,R-HSA-193704
p75NTR regulates axonogenesis,R-HSA-193697
Axonal growth inhibition (RHOA activation),R-HSA-193634
Axonal growth stimulation,R-HSA-209563
Ceramide signalling,R-HSA-193681
Regulated proteolysis of p75NTR,R-HSA-193692
p75NTR signals via NF-kB,R-HSA-193639
NF-kB is activated and signals survival,R-HSA-209560
p75NTR recruits signalling complexes,R-HSA-209543
"Cell death signalling via NRAGE, NRIF and NADE",R-HSA-204998
NADE modulates death signalling,R-HSA-205025
NRAGE signals death through JNK,R-HSA-193648
NRIF signals cell death from the nucleus,R-HSA-205043
NFG and proNGF binds to p75NTR,R-HSA-205017
p75NTR negatively regulates cell cycle via SC1,R-HSA-193670
NGF processing,R-HSA-167060
NGF signalling via TRKA from the plasma membrane,R-HSA-187037
PI3K/AKT activation,R-HSA-198203
PIP3 activates AKT signaling,R-HSA-1257604
AKT phosphorylates targets in the nucleus,R-HSA-198693
Negative regulation of the PI3K/AKT network,R-HSA-199418
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",R-HSA-6811558
AKT phosphorylates targets in the cytosol,R-HSA-198323
Signalling to STAT3,R-HSA-198745
Nuclear Events (kinase and transcription factor activation),R-HSA-198725
CREB phosphorylation,R-HSA-199920
ERK/MAPK targets,R-HSA-198753
ERKs are inactivated,R-HSA-202670
Activation of TRKA receptors,R-HSA-187015
NGF-independant TRKA activation,R-HSA-187024
TRKA activation by NGF,R-HSA-187042
PLC-gamma1 signalling,R-HSA-167021
DAG and IP3 signaling,R-HSA-1489509
CaM pathway,R-HSA-111997
Calmodulin induced events,R-HSA-111933
PKA-mediated phosphorylation of CREB,R-HSA-111931
PKA activation,R-HSA-163615
CaMK IV-mediated phosphorylation of CREB,R-HSA-111932
Cam-PDE 1 activation,R-HSA-111957
Signalling to ERKs,R-HSA-187687
Signalling to p38 via RIT and RIN,R-HSA-187706
RAF/MAP kinase cascade,R-HSA-5673001
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
RAF activation,R-HSA-5673000
MAP2K and MAPK activation,R-HSA-5674135
Regulation of RAS by GAPs,R-HSA-5658442
Prolonged ERK activation events,R-HSA-169893
ARMS-mediated activation,R-HSA-170984
RAF/MAP kinase cascade,R-HSA-5673001
RAF activation,R-HSA-5673000
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
MAP2K and MAPK activation,R-HSA-5674135
Regulation of RAS by GAPs,R-HSA-5658442
Frs2-mediated activation,R-HSA-170968
RAF/MAP kinase cascade,R-HSA-5673001
Regulation of RAS by GAPs,R-HSA-5658442
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
MAP2K and MAPK activation,R-HSA-5674135
RAF activation,R-HSA-5673000
Signalling to RAS,R-HSA-167044
p38MAPK events,R-HSA-171007
RAF/MAP kinase cascade,R-HSA-5673001
RAF activation,R-HSA-5673000
Regulation of RAS by GAPs,R-HSA-5658442
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
MAP2K and MAPK activation,R-HSA-5674135
Feedback control in the MAPK signaling module,R-HSA-197529
Retrograde neurotrophin signalling,R-HSA-177504
Signalling to ERK5,R-HSA-198765
Signaling by FGFR,R-HSA-190236
Signaling by FGFR2,R-HSA-5654738
Negative regulation of FGFR2 signaling,R-HSA-5654727
Spry regulation of FGF signaling,R-HSA-1295596
FGFR2 alternative splicing,R-HSA-6803529
FGFR2 ligand binding and activation,R-HSA-190241
FGFR2b ligand binding and activation,R-HSA-190377
FGFR2c ligand binding and activation,R-HSA-190375
Downstream signaling of activated FGFR2,R-HSA-5654696
PI-3K cascade:FGFR2,R-HSA-5654695
PIP3 activates AKT signaling,R-HSA-1257604
AKT phosphorylates targets in the nucleus,R-HSA-198693
Negative regulation of the PI3K/AKT network,R-HSA-199418
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",R-HSA-6811558
AKT phosphorylates targets in the cytosol,R-HSA-198323
Phospholipase C-mediated cascade; FGFR2,R-HSA-5654221
DAG and IP3 signaling,R-HSA-1489509
CaM pathway,R-HSA-111997
Calmodulin induced events,R-HSA-111933
PKA-mediated phosphorylation of CREB,R-HSA-111931
PKA activation,R-HSA-163615
CaMK IV-mediated phosphorylation of CREB,R-HSA-111932
Cam-PDE 1 activation,R-HSA-111957
FRS-mediated FGFR2 signaling,R-HSA-5654700
RAF/MAP kinase cascade,R-HSA-5673001
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
RAF activation,R-HSA-5673000
Regulation of RAS by GAPs,R-HSA-5658442
MAP2K and MAPK activation,R-HSA-5674135
SHC-mediated cascade:FGFR2,R-HSA-5654699
Signaling by FGFR1,R-HSA-5654736
Negative regulation of FGFR1 signaling,R-HSA-5654726
Spry regulation of FGF signaling,R-HSA-1295596
Downstream signaling of activated FGFR1,R-HSA-5654687
FRS-mediated FGFR1 signaling,R-HSA-5654693
RAF/MAP kinase cascade,R-HSA-5673001
MAP2K and MAPK activation,R-HSA-5674135
Regulation of RAS by GAPs,R-HSA-5658442
RAF activation,R-HSA-5673000
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
PI-3K cascade:FGFR1,R-HSA-5654689
PIP3 activates AKT signaling,R-HSA-1257604
Negative regulation of the PI3K/AKT network,R-HSA-199418
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",R-HSA-6811558
AKT phosphorylates targets in the nucleus,R-HSA-198693
AKT phosphorylates targets in the cytosol,R-HSA-198323
Phospholipase C-mediated cascade: FGFR1,R-HSA-5654219
DAG and IP3 signaling,R-HSA-1489509
CaM pathway,R-HSA-111997
Calmodulin induced events,R-HSA-111933
Cam-PDE 1 activation,R-HSA-111957
CaMK IV-mediated phosphorylation of CREB,R-HSA-111932
PKA-mediated phosphorylation of CREB,R-HSA-111931
PKA activation,R-HSA-163615
SHC-mediated cascade:FGFR1,R-HSA-5654688
FGFRL1 modulation of FGFR1 signaling,R-HSA-5658623
FGFR1 ligand binding and activation,R-HSA-190242
FGFR1c ligand binding and activation,R-HSA-190373
FGFR1c and Klotho ligand binding and activation,R-HSA-190374
FGFR1b ligand binding and activation,R-HSA-190370
Signaling by FGFR4,R-HSA-5654743
Downstream signaling of activated FGFR4,R-HSA-5654716
SHC-mediated cascade:FGFR4,R-HSA-5654719
PI-3K cascade:FGFR4,R-HSA-5654720
PIP3 activates AKT signaling,R-HSA-1257604
AKT phosphorylates targets in the cytosol,R-HSA-198323
Negative regulation of the PI3K/AKT network,R-HSA-199418
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",R-HSA-6811558
AKT phosphorylates targets in the nucleus,R-HSA-198693
Phospholipase C-mediated cascade; FGFR4,R-HSA-5654228
DAG and IP3 signaling,R-HSA-1489509
CaM pathway,R-HSA-111997
Calmodulin induced events,R-HSA-111933
CaMK IV-mediated phosphorylation of CREB,R-HSA-111932
Cam-PDE 1 activation,R-HSA-111957
PKA-mediated phosphorylation of CREB,R-HSA-111931
PKA activation,R-HSA-163615
FRS-mediated FGFR4 signaling,R-HSA-5654712
RAF/MAP kinase cascade,R-HSA-5673001
MAP2K and MAPK activation,R-HSA-5674135
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
Regulation of RAS by GAPs,R-HSA-5658442
RAF activation,R-HSA-5673000
FGFR4 ligand binding and activation,R-HSA-190322
betaKlotho-mediated ligand binding,R-HSA-1307965
Negative regulation of FGFR4 signaling,R-HSA-5654733
Spry regulation of FGF signaling,R-HSA-1295596
Signaling by FGFR3,R-HSA-5654741
Downstream signaling of activated FGFR3,R-HSA-5654708
SHC-mediated cascade:FGFR3,R-HSA-5654704
PI-3K cascade:FGFR3,R-HSA-5654710
PIP3 activates AKT signaling,R-HSA-1257604
AKT phosphorylates targets in the nucleus,R-HSA-198693
Negative regulation of the PI3K/AKT network,R-HSA-199418
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",R-HSA-6811558
AKT phosphorylates targets in the cytosol,R-HSA-198323
FRS-mediated FGFR3 signaling,R-HSA-5654706
RAF/MAP kinase cascade,R-HSA-5673001
Regulation of RAS by GAPs,R-HSA-5658442
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
MAP2K and MAPK activation,R-HSA-5674135
RAF activation,R-HSA-5673000
Phospholipase C-mediated cascade; FGFR3,R-HSA-5654227
DAG and IP3 signaling,R-HSA-1489509
CaM pathway,R-HSA-111997
Calmodulin induced events,R-HSA-111933
Cam-PDE 1 activation,R-HSA-111957
PKA-mediated phosphorylation of CREB,R-HSA-111931
PKA activation,R-HSA-163615
CaMK IV-mediated phosphorylation of CREB,R-HSA-111932
FGFR3 ligand binding and activation,R-HSA-190239
FGFR3b ligand binding and activation,R-HSA-190371
FGFR3c ligand binding and activation,R-HSA-190372
Negative regulation of FGFR3 signaling,R-HSA-5654732
Spry regulation of FGF signaling,R-HSA-1295596
Signaling by ERBB2,R-HSA-1227986
PI3K events in ERBB2 signaling,R-HSA-1963642
GRB2 events in ERBB2 signaling,R-HSA-1963640
PLCG1 events in ERBB2 signaling,R-HSA-1251932
ERBB2 Regulates Cell Motility,R-HSA-6785631
GRB7 events in ERBB2 signaling,R-HSA-1306955
ERBB2 Activates PTK6 Signaling,R-HSA-8847993
SHC1 events in ERBB2 signaling,R-HSA-1250196
Downregulation of ERBB2:ERBB3 signaling,R-HSA-1358803
Signaling by Insulin receptor,R-HSA-74752
Insulin receptor recycling,R-HSA-77387
Insulin receptor signalling cascade,R-HSA-74751
IRS activation,R-HSA-74713
IRS-mediated signalling,R-HSA-112399
SOS-mediated signalling,R-HSA-112412
RAF/MAP kinase cascade,R-HSA-5673001
Regulation of RAS by GAPs,R-HSA-5658442
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
MAP2K and MAPK activation,R-HSA-5674135
RAF activation,R-HSA-5673000
PI3K Cascade,R-HSA-109704
PKB-mediated events,R-HSA-109703
PDE3B signalling,R-HSA-165160
mTOR signalling,R-HSA-165159
Inhibition of TSC complex formation by PKB,R-HSA-165181
Energy dependent regulation of mTOR by LKB1-AMPK,R-HSA-380972
mTORC1-mediated signalling,R-HSA-166208
Activation of AKT2,R-HSA-165158
Signal attenuation,R-HSA-74749
Visual phototransduction,R-HSA-2187338
The retinoid cycle in cones (daylight vision),R-HSA-2187335
Retinoid metabolism and transport,R-HSA-975634
The canonical retinoid cycle in rods (twilight vision),R-HSA-2453902
"Biosynthesis of A2E, implicated in retinal degradation",R-HSA-2466712
The phototransduction cascade,R-HSA-2514856
"Inactivation, recovery and regulation of the phototransduction cascade",R-HSA-2514859
Activation of the phototransduction cascade,R-HSA-2485179
Signaling by VEGF,R-HSA-194138
Neurophilin interactions with VEGF and VEGFR,R-HSA-194306
VEGF ligand-receptor interactions,R-HSA-194313
VEGF binds to VEGFR leading to receptor dimerization,R-HSA-195399
VEGFA-VEGFR2 Pathway,R-HSA-4420097
VEGFR2 mediated vascular permeability,R-HSA-5218920
VEGFR2 mediated cell proliferation,R-HSA-5218921
RAF/MAP kinase cascade,R-HSA-5673001
Regulation of RAS by GAPs,R-HSA-5658442
MAP2K and MAPK activation,R-HSA-5674135
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
RAF activation,R-HSA-5673000
Signaling by ERBB4,R-HSA-1236394
SHC1 events in ERBB4 signaling,R-HSA-1250347
RAF/MAP kinase cascade,R-HSA-5673001
RAF activation,R-HSA-5673000
Regulation of RAS by GAPs,R-HSA-5658442
MAP2K and MAPK activation,R-HSA-5674135
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
Downregulation of ERBB4 signaling,R-HSA-1253288
Nuclear signaling by ERBB4,R-HSA-1251985
Prolactin receptor signaling,R-HSA-1170546
PI3K events in ERBB4 signaling,R-HSA-1250342
PIP3 activates AKT signaling,R-HSA-1257604
AKT phosphorylates targets in the nucleus,R-HSA-198693
Negative regulation of the PI3K/AKT network,R-HSA-199418
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",R-HSA-6811558
AKT phosphorylates targets in the cytosol,R-HSA-198323
Signaling by PDGF,R-HSA-186797
Downstream signal transduction,R-HSA-186763
PIP3 activates AKT signaling,R-HSA-1257604
AKT phosphorylates targets in the cytosol,R-HSA-198323
Negative regulation of the PI3K/AKT network,R-HSA-199418
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",R-HSA-6811558
AKT phosphorylates targets in the nucleus,R-HSA-198693
RAF/MAP kinase cascade,R-HSA-5673001
MAP2K and MAPK activation,R-HSA-5674135
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
Regulation of RAS by GAPs,R-HSA-5658442
RAF activation,R-HSA-5673000
DAG and IP3 signaling,R-HSA-1489509
CaM pathway,R-HSA-111997
Calmodulin induced events,R-HSA-111933
PKA-mediated phosphorylation of CREB,R-HSA-111931
PKA activation,R-HSA-163615
Cam-PDE 1 activation,R-HSA-111957
CaMK IV-mediated phosphorylation of CREB,R-HSA-111932
Signaling by Hippo,R-HSA-2028269
Signaling by Wnt,R-HSA-195721
WNT ligand biogenesis and trafficking,R-HSA-3238698
Beta-catenin independent WNT signaling,R-HSA-3858494
Ca2+ pathway,R-HSA-4086398
PCP/CE pathway,R-HSA-4086400
"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",R-HSA-5140745
Asymmetric localization of PCP proteins,R-HSA-4608870
WNT5A-dependent internalization of FZD4,R-HSA-5099900
Degradation of beta-catenin by the destruction complex,R-HSA-195253
Repression of WNT target genes,R-HSA-4641265
Beta-catenin phosphorylation cascade,R-HSA-196299
TCF dependent signaling in response to WNT,R-HSA-201681
Degradation of AXIN,R-HSA-4641257
Degradation of DVL,R-HSA-4641258
Regulation of FZD by ubiquitination,R-HSA-4641263
Deactivation of the beta-catenin transactivating complex,R-HSA-3769402
Negative regulation of TCF-dependent signaling by WNT ligand antagonists,R-HSA-3772470
WNT mediated activation of DVL,R-HSA-201688
Negative regulation of TCF-dependent signaling by DVL-interacting proteins,R-HSA-5368598
Formation of the beta-catenin:TCF transactivating complex,R-HSA-201722
Binding of TCF/LEF:CTNNB1 to target gene promoters,R-HSA-4411364
Disassembly of the destruction complex and recruitment of AXIN to the membrane,R-HSA-4641262
Signaling by Activin,R-HSA-1502540
Antagonism of Activin by Follistatin,R-HSA-2473224
Signaling by SCF-KIT,R-HSA-1433557
Regulation of KIT signaling,R-HSA-1433559
PIP3 activates AKT signaling,R-HSA-1257604
AKT phosphorylates targets in the cytosol,R-HSA-198323
Negative regulation of the PI3K/AKT network,R-HSA-199418
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",R-HSA-6811558
AKT phosphorylates targets in the nucleus,R-HSA-198693
RAF/MAP kinase cascade,R-HSA-5673001
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
RAF activation,R-HSA-5673000
MAP2K and MAPK activation,R-HSA-5674135
Regulation of RAS by GAPs,R-HSA-5658442
MAPK family signaling cascades,R-HSA-5683057
MAPK6/MAPK4 signaling,R-HSA-5687128
MAPK1/MAPK3 signaling,R-HSA-5684996
RAF-independent MAPK1/3 activation,R-HSA-112409
MAPK1 (ERK2) activation,R-HSA-112411
MAPK3 (ERK1) activation,R-HSA-110056
RAF/MAP kinase cascade,R-HSA-5673001
Negative regulation of MAPK pathway,R-HSA-5675221
Negative feedback regulation of MAPK pathway,R-HSA-5674499
MAP2K and MAPK activation,R-HSA-5674135
Regulation of RAS by GAPs,R-HSA-5658442
RAF activation,R-HSA-5673000
Signaling by NOTCH,R-HSA-157118
Signaling by NOTCH1,R-HSA-1980143
NOTCH1 Intracellular Domain Regulates Transcription,R-HSA-2122947
Activated NOTCH1 Transmits Signal to the Nucleus,R-HSA-2122948
Signaling by NOTCH3,R-HSA-1980148
Pre-NOTCH Expression and Processing,R-HSA-1912422
Pre-NOTCH Processing in the Endoplasmic Reticulum,R-HSA-1912399
Pre-NOTCH Transcription and Translation,R-HSA-1912408
Pre-NOTCH Processing in Golgi,R-HSA-1912420
Signaling by NOTCH2,R-HSA-1980145
NOTCH2 intracellular domain regulates transcription,R-HSA-2197563
NOTCH2 Activation and Transmission of Signal to the Nucleus,R-HSA-2979096
Signaling by NOTCH4,R-HSA-1980150
Signaling by MST1,R-HSA-8852405
